<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32116690</article-id>
<article-id pub-id-type="pmc">7010861</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2020.00002</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Immune Challenges and Seizures: How Do Early Life Insults Influence Epileptogenesis?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Semple</surname>
<given-names>Bridgette D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/28153" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dill</surname>
<given-names>Larissa K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O'Brien</surname>
<given-names>Terence J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Neuroscience, Central Clinical School, Monash University</institution>, <addr-line>Melbourne, VIC</addr-line>, <country>Australia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Medicine, Royal Melbourne Hospital, The University of Melbourne</institution>, <addr-line>Parkville, VIC</addr-line>, <country>Australia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Neurology, Alfred Health</institution>, <addr-line>Melbourne, VIC</addr-line>, <country>Australia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Stella Dracheva, Icahn School of Medicine at Mount Sinai, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Lotje D. De Witte, Icahn School of Medicine at Mount Sinai, United States; Annamaria Vezzani, Istituto Di Ricerche Farmacologiche Mario Negri, Italy; Giovambattista De Sarro, University of Catanzaro, Italy</p>
</fn>
<corresp id="fn001">*Correspondence: Bridgette D. Semple, <email xlink:href="mailto:Bridgette.Semple@monash.edu" xlink:type="simple">Bridgette.Semple@monash.edu</email>
</corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>2</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Semple, Dill and O'Brien</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Semple, Dill and O'Brien</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The development of epilepsy, a process known as epileptogenesis, often occurs later in life following a prenatal or early postnatal insult such as cerebral ischemia, stroke, brain trauma, or infection. These insults share common pathophysiological pathways involving innate immune activation including neuroinflammation, which is proposed to play a critical role in epileptogenesis. This review provides a comprehensive overview of the latest preclinical evidence demonstrating that early life immune challenges influence neuronal hyperexcitability and predispose an individual to later life epilepsy. Here, we consider the range of brain insults that may promote the onset of chronic recurrent spontaneous seizures at adulthood, spanning intrauterine insults (e.g. maternal immune activation), perinatal injuries (e.g. hypoxic–ischemic injury, perinatal stroke), and insults sustained during early postnatal life—such as fever-induced febrile seizures, traumatic brain injuries, infections, and environmental stressors. Importantly, all of these insults represent, to some extent, an immune challenge, triggering innate immune activation and implicating both central and systemic inflammation as drivers of epileptogenesis. Increasing evidence suggests that pro-inflammatory cytokines such as interleukin-1 and subsequent signaling pathways are important mediators of seizure onset and recurrence, as well as neuronal network plasticity changes in this context. Our current understanding of how early life immune challenges prime microglia and astrocytes will be explored, as well as how developmental age is a critical determinant of seizure susceptibility. Finally, we will consider the paradoxical phenomenon of preconditioning, whereby these same insults may conversely provide neuroprotection. Together, an improved appreciation of the neuroinflammatory mechanisms underlying the long-term epilepsy risk following early life insults may provide insight into opportunities to develop novel immunological anti-epileptogenic therapeutic strategies.</p>
</abstract>
<kwd-group>
<kwd>epilepsy</kwd>
<kwd>seizure</kwd>
<kwd>immune response</kwd>
<kwd>cytokines</kwd>
<kwd>interleukin-1</kwd>
<kwd>brain injury</kwd>
<kwd>neuroinflammation</kwd>
<kwd>development</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Monash University<named-content content-type="fundref-id">10.13039/501100001779</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">National Health and Medical Research Council<named-content content-type="fundref-id">10.13039/501100000925</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="153"></ref-count>
<page-count count="14"></page-count>
<word-count count="7447"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Epilepsy may develop later in life following a prenatal or early postnatal insult such as cerebral ischemia, stroke, brain trauma, or infection. These so-called “acquired epilepsies” account for approximately one-third of all human epilepsies (<xref ref-type="bibr" rid="B36">Engel, 1996</xref>; <xref ref-type="bibr" rid="B128">Thomas and Berkovic, 2014</xref>), and present clinically after a latent period of variable length (months to years) following the precipitating insult. During this time the brain undergoes progressive changes in neuronal connectivity and intrinsic excitability to ultimately result in an increased propensity for spontaneous recurrent seizures (a process known as “epileptogenesis”) to occur (<xref ref-type="bibr" rid="B85">Lowenstein, 1996</xref>; <xref ref-type="bibr" rid="B62">Herman, 2002</xref>). While diverse in nature, early life insults that have been associated with the subsequent development of epilepsy share common pathophysiological pathways involving innate immune activation, including neuroinflammation, which is proposed to play a critical role in epileptogenesis (<xref ref-type="bibr" rid="B136">Vezzani et al., 2011a</xref>; <xref ref-type="bibr" rid="B10">Becker, 2018</xref>).</p>
<p>The developing brain undergoes significant dynamic changes during fetal and early postnatal life, rendering it particularly vulnerable to insults and stressors which can have either transient or permanent effects on neuronal function (<xref ref-type="bibr" rid="B61">Herlenius and Lagercrantz, 2004</xref>). Indeed, the developing brain at baseline has an increased propensity for seizure activity compared to the adult brain (<xref ref-type="bibr" rid="B58">Hauser, 1995</xref>), thought to be attributed at least in part to the abundant excitatory circuits but fewer inhibitory circuits in the neonatal brain (<xref ref-type="bibr" rid="B93">Nardou et al., 2013</xref>). Further, the developing brain appears to be primed to respond to immune challenges in such a way that predisposes the brain towards seizure induction (<xref ref-type="bibr" rid="B13">Bilbo and Schwarz, 2012</xref>; <xref ref-type="bibr" rid="B94">Nasr et al., 2019</xref>). Immune challenges and the subsequent immune response, including neuroinflammation, are increasingly recognized as an important factor in the pathophysiology of seizure generation, seizure-related neuropathology, and epileptogenesis (<xref ref-type="bibr" rid="B49">Galic et al., 2008</xref>; <xref ref-type="bibr" rid="B110">Riazi et al., 2010</xref>; <xref ref-type="bibr" rid="B136">Vezzani et al., 2011a</xref>).</p>
<p>Several mechanisms have been proposed to explain how and why prenatal, perinatal, and postnatal insults, such as those described above, result in a vulnerability to develop acquired epilepsy later in life. For example, modulation of gene transcription and epigenetic programming, acquired channel and synaptopathies, and neuronal network connectivity all likely play an important role, as discussed elsewhere (<xref ref-type="bibr" rid="B10">Becker, 2018</xref>). Here, we focus on evidence surrounding the hypothesis that inflammation promotes epileptogenesis, elaborating on data regarding soluble inflammatory mediators as well as cellular contributions in this process.</p>
<p>Neuroinflammation, defined as an inflammatory response within the brain or spinal cord, is a common consequence of brain injuries, insults, and immune challenges (<xref ref-type="bibr" rid="B30">Disabato et al., 2017</xref>). Characterized by the release of inflammatory mediators including pro- and anti-inflammatory cytokines, complement proteins and danger signals, activation of innate immune cells, astrocytes and microglia, and recruitment of blood-derived leukocytes into the central nervous system (CNS), neuroinflammation is also a common feature of temporal lobe epilepsy (TLE) in both patients and animal models (<xref ref-type="bibr" rid="B108">Ravizza et al., 2011</xref>; <xref ref-type="bibr" rid="B136">Vezzani et al., 2011a</xref>; <xref ref-type="bibr" rid="B27">De Vries et al., 2016</xref>). As reviewed in depth elsewhere, increasing evidence suggests that inflammation represents a causal mechanism that can also initiate and perpetuate seizure activity (<xref ref-type="bibr" rid="B136">Vezzani et al., 2011a</xref>; <xref ref-type="bibr" rid="B142">Webster et al., 2017</xref>), contributing to both ictogenesis (the onset of a seizure) and epileptogenesis (<xref ref-type="bibr" rid="B138">Vezzani et al., 2019</xref>).</p>
<p>In this review, we will consider the most common early life insults linked to the development of epilepsy later in life—including prenatal immune activation, perinatal injuries, and immune challenges sustained during early postnatal life (such as infections, neurotrauma, and even seizures themselves) (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>). While not all of the described insults are purely immune-mediated—and indeed, are known to involve other biological mechanisms (e.g. environmental stress and neurotrauma)— we have incorporated these insults here in review to highlight how a range of distinctly different insults during early life can similarly yield a propensity for later life epilepsy. Much of the mechanistic evidence to date is preclinical, utilizing rodent models at postnatal day (p) 0–5 to correspond roughly to the third trimester prenatal in humans, p7–12 equivalent to the human infant at birth, and p21 to model the transition to early childhood (<xref ref-type="bibr" rid="B117">Semple et al., 2013</xref>). Specifically, we focus on evidence of the neurobiological mechanisms underlying the chronic consequences of such insults; in particular, the neuroinflammatory response. Together, this review provides a wide-ranging overview of how and why epilepsy may develop after insults to the developing brain <italic>via</italic> neuroimmune modulation. Such an understanding is necessary to inform the development and appropriate application of novel therapeutic agents targeting the relevant biological mechanisms, with the goal of disrupting and preventing the epileptogenic process from occurring.</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>Schematic summary of prenatal, perinatal, and postnatal insults to the developing human brain that initiate an inflammatory immune response, including the release of pro-inflammatory cytokines interleukin (IL)-1β, tumor necrosis factor alpha (TNFα), IL-6 and others. Experimental models have revealed that these cytokines promote astrocyte and microglial reactivity, and contribute to neuronal dysfunction by several mechanisms including alterations in neurotransmitter receptor subunit expression. These changes may lead to hyperexcitability or a reduced seizure threshold, resulting in an increased vulnerability to epilepsy. Epilepsy may develop over time and can be accelerated or triggered by a second-hit insult, such as a later life immune challenge.</p>
</caption>
<graphic xlink:href="fphar-11-00002-g001"></graphic>
</fig>
</sec>
<sec id="s2">
<title>Prenatal Insults</title>
<p>Prenatal life is a time of unique immunological status for a developing fetus, which is intricately associated with maternal health status. A large and growing body of literature provides evidence that infections and other immune challenges sustained during pregnancy can influence fetal brain development, with <italic>in utero</italic> exposure to infections and/or inflammation considered to be an environmental risk factor for neurodevelopmental and psychiatric disorders including autism and schizophrenia (<xref ref-type="bibr" rid="B122">Solek et al., 2018</xref>; <xref ref-type="bibr" rid="B57">Guma et al., 2019</xref>).</p>
<p>Epidemiological data has suggested a relationship between maternal infections and a high incidence of childhood epilepsy in offspring (<xref ref-type="bibr" rid="B95">Norgaard et al., 2012</xref>). Several large population-based cohort studies have reported the greatest risk of epilepsy in the offspring of mothers who sustained infections resulting in fever during early to mid-pregnancy (<xref ref-type="bibr" rid="B126">Sun et al., 2008</xref>; <xref ref-type="bibr" rid="B127">Sun et al., 2011</xref>). Experimentally, this scenario can be modeled in rodents by evoking an infection-like immune challenge to pregnant dams, then assessing the seizure susceptibility of the resulting offspring. Lipopolysaccharide (LPS), a component of the cell wall of gram-negative bacteria and commonly used experimental immunogen to model a bacterial infection, results in persistent changes in neuronal excitability <italic>in vitro</italic> (<xref ref-type="bibr" rid="B56">Gullo et al., 2014</xref>), and exacerbates hippocampal excitability in electrical kindling models <italic>in vivo</italic> (<xref ref-type="bibr" rid="B9">Auvin et al., 2010b</xref>). When embryos are exposed to LPS <italic>via</italic> inoculation of the pregnant dam at gestational days 15–16, a second challenge at p21—injection of the L-glutamate analog kainic acid (KA)—revealed increased seizure susceptibility compared to those exposed to saline control (<xref ref-type="bibr" rid="B150">Yin et al., 2015</xref>). This finding was associated with exacerbated, long-lasting astrogliosis, and worsened spatial learning ability when assessed at adulthood (<xref ref-type="bibr" rid="B150">Yin et al., 2015</xref>). Astrocytes, as the most numerous glial cells in the CNS, play many essential roles in tissue homeostasis, synaptic transmission, and neuroimmune responses (<xref ref-type="bibr" rid="B39">Farina et al., 2007</xref>; <xref ref-type="bibr" rid="B21">Clarke and Barres, 2013</xref>). Accumulating compelling evidence suggests that aberrant astrocyte activation contributes to the pathophysiology of epilepsy (<xref ref-type="bibr" rid="B26">De Lanerolle et al., 2010</xref>; <xref ref-type="bibr" rid="B150">Yin et al., 2015</xref>; <xref ref-type="bibr" rid="B99">Patel et al., 2019</xref>). Together with epidemiological evidence that systemic inflammation increases an individuals' susceptibility to seizures by lowering their seizure threshold (<xref ref-type="bibr" rid="B151">Yuen et al., 2018</xref>), these studies provide the foundation for the hypothesis that inflammation is a critical modulator of brain excitability.</p>
<p>Polyinosinic:polycytidylic acid (poly I:C) is an experimental substrate frequently used to mimic viral infections. When administered to gestating animals in a model known as maternal immune activation (MIA), this toll-like receptor 3 (TLR3) agonist results in long-lasting physiological perturbations (<xref ref-type="bibr" rid="B91">Meyer, 2014</xref>). Poly I:C administration to pregnant mice between embryonic days 12 to 16 results in the offspring exhibiting increased vulnerability to hippocampal kindling, with strong evidence supporting a role for the cytokines interleukin (IL)-6 and IL-1β in these effects (<xref ref-type="bibr" rid="B103">Pineda et al., 2013</xref>). The dependence of these effects on signaling <italic>via</italic> TLR3 was demonstrated by use of TLR3 gene deficient mice, albeit at adulthood, which show a reduced propensity to develop epileptic seizures after administration of the proconvulsant pilocarpine (<xref ref-type="bibr" rid="B55">Gross et al., 2017</xref>).</p>
<p>Several cytokines are known to have both acute and long-lasting effects on neuronal excitability, with IL-1β being the best characterized to date. Systemic or intracerebral administration of LPS or poly I:C to the mother rodent (or offspring; see the section <italic>Infections in Postnatal Life</italic>) provokes an acute elevation of pro-inflammatory cytokines <italic>via</italic> gene transcription of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in neurons and glia of the mother and offspring (<xref ref-type="bibr" rid="B103">Pineda et al., 2013</xref>). By triggering a systemic immune response in the mother, gestational infections mimicked by LPS or poly I:C appear to also comprise the fetal placental barrier, allowing entry of maternally derived cytokines and other molecules (e.g. glucocorticoids) into the fetal circulation, where they can influence the developing fetal brain (<xref ref-type="bibr" rid="B91">Meyer, 2014</xref>). The extent to which maternally derived factors cross the placenta—a process known as “vertical transfer”—is incompletely understood, but appears to be cytokine-specific, and may be <italic>via</italic> either direct or passive transport (<xref ref-type="bibr" rid="B152">Zaretsky et al., 2004</xref>; <xref ref-type="bibr" rid="B52">Gilmore et al., 2005</xref>; <xref ref-type="bibr" rid="B25">Dahlgren et al., 2006</xref>). Regardless, abundant studies have demonstrated that a wide range of cytokines are increased in the fetal brain within hours after MIA in pregnant rodents, including IL-1β, tumor necrosis factor alpha (TNFα), and IL-6 (<xref ref-type="bibr" rid="B122">Solek et al., 2018</xref>). Activated microglia are likely to be a major source of inflammatory mediators in this context (<xref ref-type="bibr" rid="B102">Perry and Holmes, 2014</xref>). These cytokines can then act both directly and indirectly to modulate neuronal excitability and neurotransmission—for example, by altering the subunit composition of glutamatergic and gamma-aminobutyric acid (GABA)-ergic receptors (<xref ref-type="bibr" rid="B136">Vezzani et al., 2011a</xref>; <xref ref-type="bibr" rid="B137">Vezzani et al., 2011b</xref>; <xref ref-type="bibr" rid="B133">Vezzani and Viviani, 2015</xref>).</p>
<p>In the poly I:C MIA model, antibody blocking experiments were used to demonstrate that both IL-1β and IL-6 are required for an increased propensity for recurrent seizures (<xref ref-type="bibr" rid="B103">Pineda et al., 2013</xref>). Further evidence that IL-1β has a causative or modulatory role in network excitability stems from studies demonstrating anticonvulsive effects when IL-1β levels are reduced; either by intracerebral injection of an IL-1 receptor antagonist, transgenic overexpression of the receptor antagonist, or inhibition of interleukin-converting enzyme (<xref ref-type="bibr" rid="B107">Ravizza et al., 2008</xref>; <xref ref-type="bibr" rid="B137">Vezzani et al., 2011b</xref>).</p>
</sec>
<sec id="s3">
<title>Maternal and Environmental Stress Throughout Development</title>
<p>Environmental stress during pregnancy, and early postnatal life, may promote the development of epilepsy during later life. Increasing evidence suggests that early life stress is an important modulator of limbic epilepsy, likely <italic>via</italic> effects on endocrine function, neuroplasticity, neurotransmission, and cellular electrophysiology (<xref ref-type="bibr" rid="B78">Koe et al., 2009</xref>). MIA and other forms of maternal stress, such as separation of dam from pups or early handling of pups, may also be considered as an early life stressor which aggravates epileptogenesis in both status epilepticus (SE) and kindling models (<xref ref-type="bibr" rid="B116">Salzberg et al., 2007</xref>). Additionally, stress resulting from transport of dams during pregnancy, as well as maternal behaviors and early postnatal malnutrition, have all been demonstrated to promote susceptibility to KA or amygdala kindling-induced seizures of the offspring during later life (<xref ref-type="bibr" rid="B116">Salzberg et al., 2007</xref>; <xref ref-type="bibr" rid="B92">Moriyama et al., 2013</xref>; <xref ref-type="bibr" rid="B121">Simao et al., 2016</xref>).</p>
<p>Maternal glucocorticoids as a consequence of a hyperactive hypothalamic–pituitary–adrenocortical (HPA) axis have been proposed to be one of the key mechanisms by which maternal stress mediates network reorganization and epileptogenesis in the developing offspring (<xref ref-type="bibr" rid="B78">Koe et al., 2009</xref>; <xref ref-type="bibr" rid="B81">Kumar et al., 2011</xref>; <xref ref-type="bibr" rid="B71">Jones et al., 2014</xref>; <xref ref-type="bibr" rid="B147">Wulsin et al., 2016</xref>). Another mechanism is <italic>via</italic> disruption of the GABA switch, a developmentally regulated functional change in GABA signaling from excitatory to inhibitory that occurs in the first 1–2 postnatal weeks (<xref ref-type="bibr" rid="B11">Ben-Ari, 2002</xref>). Neonatal stress from maternal separation has been found to delay the timing of the GABA switch in the mouse hippocampus, with consequences for behavior at adolescence (<xref ref-type="bibr" rid="B48">Furukawa et al., 2017</xref>). This study suggests that early life insults can disrupt or modify this essential step in GABAergic maturation and the resulting neuronal excitation/inhibition balance—which could have consequences for seizure propensity also. Indeed, the poly I:C MIA model has also been shown to delay the GABA switch in mice, resulting in hyperexcitability of neuronal networks and higher susceptibility to seizures at adulthood (<xref ref-type="bibr" rid="B22">Corradini et al., 2018</xref>).</p>
<p>Importantly, alterations in the stress response—resulting in elevated stress hormone levels—have been shown to promote chronic priming and activation of microglia, which then generate increased cytokines IL-1β, IL-6, and TNFα in response to a secondary immune challenge (<xref ref-type="bibr" rid="B42">Frank et al., 2014</xref>). This mechanism by which stress promotes increased neuroinflammation may thereby contribute to epileptogenesis in adulthood (<xref ref-type="bibr" rid="B116">Salzberg et al., 2007</xref>).</p>
</sec>
<sec id="s4">
<title>Perinatal Insults</title>
<p>Hypoxic–ischemic injury (HI) is a significant cause of brain damage in newborn infants, and is associated with a high incidence of neurodevelopmental disabilities. Neonatal hypoxic–ischemic encephalopathy, defined as a syndrome of disturbed neurological function during the first days of life, often occurs following moderate to severe HI, and is the most common cause of neonatal seizures (<xref ref-type="bibr" rid="B139">Volpe, 1989</xref>; <xref ref-type="bibr" rid="B153">Zupanc, 2004</xref>). These acute seizures likely result from excitotoxic neuronal damage and cell death, following compromised oxygen and glucose supply to the developing brain. Epilepsy is reported in 9–33% of term infants with neonatal HI (<xref ref-type="bibr" rid="B53">Glass et al., 2011</xref>), with injury to the motor cortex, hippocampus, and occipital lobe being identified as risk factors for epilepsy in this context (<xref ref-type="bibr" rid="B149">Xu et al., 2019</xref>). Ischemic stroke is another common disorder affecting approximately one in every 4,000 live births, which is associated with both acute seizures and the subsequent development of epilepsy (<xref ref-type="bibr" rid="B87">Lynch and Nelson, 2001</xref>).</p>
<p>Animal models of perinatal hypoxia, HI, or stroke have suggested that the propensity for both acute seizures and epileptogenesis after injury is age-dependent (<xref ref-type="bibr" rid="B70">Jensen et al., 1998</xref>). Using the well-established Rice–Vannucci model of perinatal HI to p7 pups (<xref ref-type="bibr" rid="B111">Rice et al., 1981</xref>), acute seizures are associated with the extent of brain damage (<xref ref-type="bibr" rid="B14">Bjorkman et al., 2010</xref>), and spontaneous recurrent seizures have been reported in a subset of animals (<xref ref-type="bibr" rid="B146">Williams et al., 2004</xref>; <xref ref-type="bibr" rid="B145">Williams and Dudek, 2007</xref>). In another stroke model, involving induction of a photothrombotic lesion in the sensorimotor cortex of p7 rodents, seizure vulnerability was evaluated in response to the GABA<sub>A</sub> receptor antagonist and pro-convulsive agent pentylenetetrazol (PTZ), an agent widely used to assess brain excitability (<xref ref-type="bibr" rid="B77">Klioueva et al., 2001</xref>). From electroencephalogram (EEG) analysis performed at 5 and 18 days post-injury (p12 and p25), early life stroke was found to result in an exacerbated response to PTZ, with a higher proportion of animals exhibiting clonic seizures, as well as longer response duration (<xref ref-type="bibr" rid="B16">Brima et al., 2013</xref>).</p>
<p>Hypoxia alone has also been shown to induce spontaneous tonic–clonic seizures in rodents, when induced at p10–12, but not in older (p15–60) or younger (p5) rats (<xref ref-type="bibr" rid="B68">Jensen et al., 1991</xref>; <xref ref-type="bibr" rid="B69">Jensen et al., 1992</xref>). These animals also displayed increased susceptibility to convulsant-induced seizures at adulthood, while hippocampal slices collected postmortem demonstrated chronic changes in CA1 hippocampal network excitability. Of note, these abnormalities were evident in the absence of overt histopathological damage or chronic neurobehavioral deficits (<xref ref-type="bibr" rid="B68">Jensen et al., 1991</xref>). In subsequent studies, hypoxic injury and HI at p7 have been shown to result in an increased vulnerability to KA challenge at 6 weeks post-injury (<xref ref-type="bibr" rid="B113">Rodriguez-Alvarez et al., 2015</xref>), as well as spontaneous epileptiform discharges and recurrent motor seizures by 2–12 months of age—but typically only in a subset of injured animals with cerebral cystic infarcts (<xref ref-type="bibr" rid="B72">Kadam et al., 2010</xref>; <xref ref-type="bibr" rid="B101">Peng et al., 2015</xref>). The frequency and severity of spontaneous behavioral and electrographic seizures increases over time, highlighting the progressive nature of epileptogenesis.</p>
<p>The contribution of inflammation to development of epilepsy in this context was recently demonstrated, by use of a novel therapeutic drug Vitexin. This anti-inflammatory botanical flavonoid was found to reduce cytokine release, neutrophil infiltration, and blood–brain barrier (BBB) permeability alongside a reduction in epilepsy susceptibility after HI in neonatal rats (<xref ref-type="bibr" rid="B86">Luo et al., 2018</xref>). In the clinic, in a small cohort study of patients with neonatal HI, elevated IL-6, TNFα, and IL-1β were found to be associated with the subsequent onset of epilepsy (<xref ref-type="bibr" rid="B96">Numis et al., 2019</xref>), suggesting that these cytokines may hold value as predictive biomarkers of later life epilepsy risk.</p>
</sec>
<sec id="s5">
<title>Postnatal Insults</title>
<sec id="s5_1">
<title>Hyperthermia-Induced Febrile Seizures</title>
<p>Febrile seizures (FS), typically provoked by fever, are common during infancy and early childhood, affecting approximately 3–5% of children between 6 months and 5 years of age (<xref ref-type="bibr" rid="B12">Berg and Shinnar, 1996</xref>; <xref ref-type="bibr" rid="B67">Jensen and Baram, 2000</xref>). When recurrent or prolonged (approximately one-third of FS), these complex seizure events can lead to sustained modification and dysfunction of hippocampal neurons, which is proposed to underlie a heightened risk of subsequent epileptogenesis and neurocognitive dysfunction during later life (<xref ref-type="bibr" rid="B33">Dube et al., 2007</xref>; <xref ref-type="bibr" rid="B65">Huang and Chang, 2009</xref>). Epidemiological studies have linked prolonged FS during childhood with the development of TLE (<xref ref-type="bibr" rid="B17">Chen et al., 1999</xref>; <xref ref-type="bibr" rid="B115">Saltik et al., 2003</xref>; <xref ref-type="bibr" rid="B47">Fukuda et al., 2015</xref>), although whether this relationship is indeed causal, and the underlying mechanisms, remains unclear. Susceptibility to the convulsant effects of hyperthermia decreases with age in both humans and rodents, such that investigation into this phenomenon may provide insight into the mechanisms that govern this developmentally specific vulnerability during early life (<xref ref-type="bibr" rid="B67">Jensen and Baram, 2000</xref>).</p>
<p>Experimentally, rodent models of hyperthermia-induced FS typically utilize p10–14 animals (<xref ref-type="bibr" rid="B60">Heida et al., 2004</xref>; <xref ref-type="bibr" rid="B59">Heida and Pittman, 2005</xref>), consistent with the time period thought to represent the neurodevelopmental transition during the first 2 weeks of life in the human (<xref ref-type="bibr" rid="B54">Gottlieb et al., 1977</xref>; <xref ref-type="bibr" rid="B117">Semple et al., 2013</xref>). This model results in increased seizure susceptibility by adulthood, evident as a reduction in seizure threshold and increased susceptibility to seizure-induced cell death after a KA second-hit (<xref ref-type="bibr" rid="B31">Dube et al., 2000</xref>; <xref ref-type="bibr" rid="B132">Van Gassen et al., 2008</xref>). Approximately 40% of these animals develop spontaneous TLE alongside neuropathology in the cortex and hippocampus. Several factors have been proposed as mechanisms of epileptogenesis in this context, including the effects of altered brain temperature, changes in the endocannabinoid system, altered GABA<sub>A</sub> subunit composition, and inflammation (<xref ref-type="bibr" rid="B40">Feng and Chen, 2016</xref>). In terms of the inflammatory response, the release and subsequent actions of IL-1β have also been strongly implicated (<xref ref-type="bibr" rid="B40">Feng and Chen, 2016</xref>). In patient populations, specific IL-1β polymorphisms have been associated with sporadic development of FS (<xref ref-type="bibr" rid="B76">Kira et al., 2005</xref>). Supporting this, administration of IL-1β after an induced FS in juvenile rats leads to a significant increase in seizure incidence compared to saline-treated controls (<xref ref-type="bibr" rid="B47">Fukuda et al., 2015</xref>), while IL-1β alone can mimic the effects of FS on adult seizure susceptibility (<xref ref-type="bibr" rid="B41">Feng et al., 2016</xref>). In another study, only rats in which IL-1β was elevated chronically went on to develop spontaneous limbic seizures after FS (<xref ref-type="bibr" rid="B34">Dube et al., 2010</xref>). In contrast, administration of the IL-1R antagonist is anticonvulsive (<xref ref-type="bibr" rid="B59">Heida and Pittman, 2005</xref>), while IL-1R–deficient mice are resistant to FS, independent of the genetic background strain (C57Bl or 129/Sv) (<xref ref-type="bibr" rid="B32">Dube et al., 2005</xref>). This mechanism holds strong promise for clinical translation, with two case reports demonstrating that treatment with the IL-1R antagonist reduced seizure burden and relapse in children with febrile infection-related epilepsy syndrome (<xref ref-type="bibr" rid="B74">Kenney-Jung et al., 2016</xref>; <xref ref-type="bibr" rid="B29">Dilena et al., 2019</xref>).</p>
</sec>
<sec id="s5_2">
<title>Infections in Postnatal Life</title>
<p>Epidemiological evidence has demonstrated that CNS and systemic infections are another major cause of acquired epilepsy (<xref ref-type="bibr" rid="B4">Annegers et al., 1988</xref>; <xref ref-type="bibr" rid="B88">Marks et al., 1992</xref>). Indeed, an episode of viral encephalitis resulting from, for example, herpes simplex or cytomegalovirus, has been reported to increase the risk of subsequent unprovoked seizures by 16-fold (<xref ref-type="bibr" rid="B4">Annegers et al., 1988</xref>). These seizures are also associated with concurrent neurological consequences, and the increased risk for both epilepsy and neurobehavioral complications may persist even after the infection has resolved for at least 20 years (<xref ref-type="bibr" rid="B4">Annegers et al., 1988</xref>; <xref ref-type="bibr" rid="B105">Raschilas et al., 2002</xref>; <xref ref-type="bibr" rid="B18">Chen et al., 2006</xref>). In the juvenile rodent, poly I:C and LPS have been extensively utilized to model infection-like immune challenges during early postnatal life, and examine the effect of such insults on brain excitability.</p>
<sec id="s5_2_1">
<title>Postnatal Poly I:C</title>
<p>In addition to use in the MIA model of a prenatal immune challenge, poly I:C is regularly employed to investigate infection-like immune challenges during early postnatal life. When injected directly into the rat hippocampus at p13–14, poly I:C induces fever and a local increase in IL-1β levels (<xref ref-type="bibr" rid="B50">Galic et al., 2009</xref>). Poly I:C facilitates electrical kindling epileptogenesis, as evident by an increased number of observed limbic seizures (<xref ref-type="bibr" rid="B35">Dupuis et al., 2016</xref>). Animals administered poly I:C at p13 demonstrated a faster seizure onset and prolonged kindled state compared to when the immune challenge was induced at adulthood (p74), again highlighting the age-dependent vulnerability of the early postnatal brain to hyperexcitability (<xref ref-type="bibr" rid="B35">Dupuis et al., 2016</xref>). Although microglia were hypothesized to play a role in these observations, administration of the tetracycline antibiotic minocycline, which has reported microglial suppressive effects (as well as other effects), prior to kindling, failed to reverse the pro-epileptogenic effects of poly I:C (<xref ref-type="bibr" rid="B35">Dupuis et al., 2016</xref>). In another study, animals exposed to poly I:C at p14 were found to be more susceptible to lithium-pilocarpine and PTZ-induced seizures at adulthood, and exhibited memory deficits in a fear conditioning paradigm (<xref ref-type="bibr" rid="B50">Galic et al., 2009</xref>). These chronic changes were coincidental with persistently altered levels of glutamate receptor subunits messenger ribonucleic acid (mRNA) expression, which were able to be suppressed by neonatal systemic minocycline, implicating a role for microglial activation as an underlying mechanism (<xref ref-type="bibr" rid="B50">Galic et al., 2009</xref>). Increased seizure susceptibility observed in adult rodents following poly I:C administration to young pups, similar to in the MIA context, is understood to depend at least in part upon early life activation of IL-1β signaling (<xref ref-type="bibr" rid="B50">Galic et al., 2009</xref>). Together, these studies demonstrate that poly I:C exposure is pro-epileptic in the early postnatal brain, similar to the prenatal brain, although the precise mechanisms (and whether these are age-dependent) remain incomplete.</p>
</sec>
<sec id="s5_2_2">
<title>Postnatal LPS</title>
<p>Perhaps the most common experimental model of postnatal infection involves administration of LPS, typically to the periphery (intraperitoneal) to p10–16 rodent pups (<xref ref-type="bibr" rid="B49">Galic et al., 2008</xref>; <xref ref-type="bibr" rid="B8">Auvin et al., 2010a</xref>). Depending upon the dose, LPS induces a transient inflammatory response within the first 12–24 h post-injection which largely resolves thereafter. Of note, a persistent increase in seizure susceptibility is evident following low dose LPS at p7–14—compared to when LPS was administered earlier (p1) or later (p20) (<xref ref-type="bibr" rid="B49">Galic et al., 2008</xref>). This time period coincides with the developmental peak in synaptogenesis and synaptic pruning, yielding considerable changes in neuronal circuitry which likely underlies this critical window of vulnerability. This paradigm has since been used to demonstrate that LPS exposure increases susceptibility to KA-induced seizures at p35, alongside impairments in long-term potentiation and exacerbated hippocampal neurodegeneration (<xref ref-type="bibr" rid="B19">Chen et al., 2013</xref>), and pilocarpine-induced seizures at 2 months of age (<xref ref-type="bibr" rid="B119">Setkowicz et al., 2017</xref>). In another study, KA was administered simultaneously with LPS to p14 pups, revealing long-lasting molecular changes alongside increased seizure excitability by adulthood. This was enhanced further in the ~50% subset of LPS + KA–treated animals that exhibited an overt behavioral seizure response FS compared to those that did not, as evidenced by increased <italic>in vitro</italic> excitability as well as modified N-methyl-D-aspartate (NMDA) and GABA<sub>A</sub> receptor subunit protein expression in the hippocampus (<xref ref-type="bibr" rid="B109">Reid et al., 2013</xref>).</p>
<p>Similarly, LPS has been shown to potentiate fever-induced FS at p14 in both rats and mice, at least acutely (<xref ref-type="bibr" rid="B38">Eun et al., 2015</xref>). Administered peripherally 2 h prior to hyperthermia-induced seizure onset, LPS promoted susceptibility of animals to seizures, alongside enhanced pro-inflammatory cytokine production and microglial activation. These findings suggest that peripheral inflammation works synergistically with hyperthermia to potentiate seizures and exacerbate the resultant immune response. Whether this combinatorial challenge also predicts heightened vulnerability to chronic epilepsy has not yet been examined.</p>
<p>Several studies have noted that the inflammatory challenge during early life is typically transient; for example, LPS-induced acute inflammation rarely lasts more than 24 h following injection. Thus significant changes in the reactivity to seizures observed in adulthood do not directly result from inflammation <italic>per se,</italic> but rather indirectly from the long-term effects of the acute inflammatory response on the immature brain, and its subsequent developmental trajectory (<xref ref-type="bibr" rid="B79">Kosonowska et al., 2015</xref>; <xref ref-type="bibr" rid="B66">Janeczko et al., 2018</xref>).</p>
<p>LPS administration triggers the abundant release of IL-1β and TNFα, which can act on receptors such as IL-1R on the hippocampal dentate gyrus to facilitate enhanced epileptiform activity (<xref ref-type="bibr" rid="B51">Gao et al., 2014</xref>). A central role for these cytokines has been demonstrated in the context of epileptogenesis following LPS in the p14 rat, which can be partially prevented by administration of either IL-1R antagonism or an anti-TNFα antibody (<xref ref-type="bibr" rid="B49">Galic et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Auvin et al., 2010b</xref>). LPS-induced seizure susceptibility was also recently shown to involve TLR4 activation, signaling <italic>via</italic> extracellular signal–regulated kinases 1 and 2 (Erk1/2), in a manner dependent on myeloid differentiation primary response 88 (MyD88) (<xref ref-type="bibr" rid="B120">Shen et al., 2016</xref>). Constitutive activation of Erk1/2 in astrocytes alone was sufficient to enhance excitatory synaptogenesis, while deleting MyD88 or suppressing Erk1/2 in astrocytes was able to ameliorate seizure sensitivity, providing direct evidence for a developmental role of astrocytes in predisposing towards epileptogenesis (<xref ref-type="bibr" rid="B120">Shen et al., 2016</xref>).</p>
<p>As noted earlier, a particular window of enhanced vulnerability to seizures has been identified in rodent models during the second week of postnatal life, coincidental with significant synaptogenesis and synaptic pruning (<xref ref-type="bibr" rid="B49">Galic et al., 2008</xref>). As microglia are known regulators of synaptic remodeling (<xref ref-type="bibr" rid="B130">Tremblay et al., 2011</xref>), and peak in cell density at around p14–28 (<xref ref-type="bibr" rid="B75">Kim et al., 2015</xref>), microglia may also govern this age-dependent susceptibility (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>). Heightened reactivity due to normal developmental changes render microglia particularly poised to mount an exaggerated inflammatory response to early life seizures or other immune challenges that are encountered at this time; and this over-reactive immunity may exacerbate acute neuronal injury thereby contributing to long-term epileptogenic effects (<xref ref-type="bibr" rid="B130">Tremblay et al., 2011</xref>; <xref ref-type="bibr" rid="B75">Kim et al., 2015</xref>).</p>
<fig id="f2" position="float">
<label>Figure 2</label>
<caption>
<p>Schematic timeline illustrating key neurodevelopmental processes ongoing through gestational and postnatal periods in the mammalian brain. A wide range of prenatal, perinatal, and postnatal insults influence the developing brain both acutely but also chronically, driving an increased propensity for neuronal hyperexcitability and seizure susceptibility during later life. Age-dependent vulnerability to these chronic consequences is thought to be determined, at least in part, by the state of microglial development (changes in number, phenotype, and activity), as well as maturation of neuronal circuits (a product of synaptogenesis and synaptic pruning over time). Adapted from <xref ref-type="bibr" rid="B117">Semple et al. (2013)</xref> and <xref ref-type="bibr" rid="B82">Lenz and Nelson (2018)</xref>.</p>
</caption>
<graphic xlink:href="fphar-11-00002-g002"></graphic>
</fig>
</sec>
</sec>
<sec id="s5_3">
<title>Postnatal Status Epilepticus</title>
<p>SE is defined as a condition in which abnormally prolonged seizures occur, which may have long-term consequences including neuronal loss and altered neuronal networks (<xref ref-type="bibr" rid="B131">Trinka et al., 2015</xref>). In experimental animals, a transient episode of SE can “convert” a previously normal brain into an epileptic one, providing a model in which to explore mechanisms of epileptogenesis (<xref ref-type="bibr" rid="B84">Lothman and Bertram, 1993</xref>). Of note, vulnerability to KA appears to be age-specific, with younger animals (p5–15) exhibiting more severe SE with a shorter latency, and higher mortality, compared to older animals (p20–60) (<xref ref-type="bibr" rid="B64">Holmes and Thompson, 1988</xref>; <xref ref-type="bibr" rid="B125">Stafstrom et al., 1992</xref>).</p>
<p>Microglia, which mediate a significant proportion of the innate immune capacity of the CNS, are critical for immune surveillance in the steady state, as well as the response to injury and disease (<xref ref-type="bibr" rid="B30">Disabato et al., 2017</xref>). Chronic microglial activation is a common component to a wide range of neurodegenerative conditions including multiple sclerosis, Alzheimer's disease, and traumatic brain injury (TBI), likely contributing to neuronal dysfunction and cell loss to facilitate disease progression. KA-induced SE triggers a time-dependent microglial activation response including the release of pro-inflammatory cytokines TNFα and IL-1β (<xref ref-type="bibr" rid="B148">Wyatt-Johnson et al., 2017</xref>), which appears to precede the appearance of neuronal damage (<xref ref-type="bibr" rid="B112">Rizzi et al., 2003</xref>; <xref ref-type="bibr" rid="B106">Ravizza et al., 2005</xref>). In this context, IL-1 signaling has again been implicated, with experiments in which IL-1β was administered prior to KA reported an increase in the time spent in seizures <italic>via</italic> an NMDA receptor–dependent mechanism (<xref ref-type="bibr" rid="B134">Vezzani et al., 1999</xref>).</p>
<p>In some instances, in response to an immune challenge, microglia are induced to a “primed” state—not activated <italic>per se</italic>, but in an intermediate phenotype which renders them able to respond more rapidly when subsequently activated, including the production of greater quantities of pro-inflammatory cytokines compared to normally activated, non-primed (or quiescent) microglia (<xref ref-type="bibr" rid="B124">Sparkman and Johnson, 2008</xref>). This appears to be the case after early life KA-induced seizures in p15 rats, followed by a second-hit exposure of KA at p45. Animals that were exposed to both KA doses had greater microglial activation, associated with elevated pro-inflammatory cytokine levels and increased susceptibility to seizures compared to saline-control animals that received the KA only at p45 (no prior exposure) (<xref ref-type="bibr" rid="B123">Somera-Molina et al., 2009</xref>). Treatment with Minozac, a small novel therapeutic compound that inhibits pro-inflammatory cytokine production, attenuated these effects. These results implicate cytokines produced by activated microglia as one mechanism by which early life seizures contribute to increased vulnerability to neurological insults in adulthood (<xref ref-type="bibr" rid="B123">Somera-Molina et al., 2009</xref>). Similarly, administration of minocycline following KA at p25 in mice has been shown to reduce vulnerability to a second SE event at p39, likely to be attributed to the suppression of microglial activation—providing further evidence that early life insults such as seizures act to prime microglia for a subsequent immune challenge (<xref ref-type="bibr" rid="B1">Abraham et al., 2012</xref>).</p>
</sec>
<sec id="s5_4">
<title>Early Life Neurotrauma</title>
<p>TBI during early childhood is another well-known cause of epilepsy. This post-traumatic epilepsy (PTE) has a reported incidence of up to 35% after severe TBI (<xref ref-type="bibr" rid="B3">Annegers et al., 1980</xref>; <xref ref-type="bibr" rid="B7">Ates et al., 2006</xref>; <xref ref-type="bibr" rid="B5">Arndt et al., 2013</xref>). While several well-characterized experimental models have been utilized in adult rodents to explore PTE after TBI to the mature brain (<xref ref-type="bibr" rid="B24">D'ambrosio et al., 2004</xref>; <xref ref-type="bibr" rid="B15">Bolkvadze and Pitkanen, 2012</xref>; <xref ref-type="bibr" rid="B73">Kelly et al., 2015</xref>; <xref ref-type="bibr" rid="B98">Ostergard et al., 2016</xref>), there has been a lack of age-appropriate models to consider the complex interaction between ongoing brain development and epileptogenesis that occurs after a TBI during early childhood.</p>
<p>An established model of experimental TBI to the p21 mouse, utilizing the controlled cortical impact model of unilateral injury to the parietal lobe, results in progressive neuropathology and chronic neurobehavioral and neurocognitive dysfunction consistent with what is commonly observed in toddler-aged children after TBI (<xref ref-type="bibr" rid="B129">Tong et al., 2002</xref>; <xref ref-type="bibr" rid="B104">Pullela et al., 2006</xref>). This model has recently been demonstrated to also reproduce many of the features characteristic of PTE in humans, including histopathological evidence of circuitry reorganization, interneuron loss, and hippocampal gliosis (<xref ref-type="bibr" rid="B118">Semple et al., 2017</xref>). Brain-injured mice exhibit both an increased vulnerability to PTZ-evoked seizures, evident as early as 2 weeks post-TBI, suggesting that epileptogenesis is underway at this time creating an environmental primed for the development of PTE. A proportion of TBI mice were reported to develop at least one spontaneous seizure within a 7-day video-EEG recording period by 4–6 months post-injury—from 15% after a moderate injury severity up to over 90% incidence after a severe injury involving considerable hippocampal pathology (<xref ref-type="bibr" rid="B118">Semple et al., 2017</xref>; <xref ref-type="bibr" rid="B143">Webster et al., 2019</xref>).</p>
<p>Although the mechanisms underlying PTE remain unclear, several lines of evidence point towards a prominent role of cytokine signaling, particularly <italic>via</italic> IL-1 (<xref ref-type="bibr" rid="B142">Webster et al., 2017</xref>). Experimentally, administration of the IL-1R antagonist attenuates both sub-acute and chronic susceptibility to PTZ-induced seizures after pediatric TBI in the mouse (<xref ref-type="bibr" rid="B118">Semple et al., 2017</xref>). Genetic data from patient populations has also implicated specific IL-1β polymorphisms with the risk of PTE after a TBI (<xref ref-type="bibr" rid="B28">Diamond et al., 2015</xref>).</p>
<p>This latter point raises and somewhat addresses an important question—why do some individuals, a minority, respond to an early life insult with epilepsy, while others who sustain a similar insult do not? Our understanding of how environmental factors (such as an early life insult) interact with genetics to promote epileptogenesis remains in its infancy. However, there is increasing evidence that genetic predisposition to epilepsy will increase an individuals' likelihood of developing late-onset seizures after an acquired insult. For example, a higher risk of post-stroke epilepsy was recently reported in individuals with a family history of epilepsy compared to those without a family history, even when adjusted for stroke injury severity (<xref ref-type="bibr" rid="B37">Eriksson et al., 2019</xref>). Similarly, in a population-based cohort study of more than 1.6 million Danish adults and children, a family history of epilepsy was associated with an approximately 10-fold higher risk of developing late-onset seizures following a severe brain injury (<xref ref-type="bibr" rid="B20">Christensen et al., 2009</xref>). Limited studies to date have specifically probed for gene associations with acquired epilepsy risk, as recently reviewed (<xref ref-type="bibr" rid="B83">Leung et al., 2019</xref>). Consistent with the abovementioned evidence on IL-1β polymorphisms and PTE risk, a meta-analysis found that specific alleles of both IL-1β and IL-1α have also been associated with risk of epilepsy after FS (<xref ref-type="bibr" rid="B114">Saghazadeh et al., 2014</xref>). Further investigation into other genes involved in the inflammatory response, and in a range of patient populations, are needed to determine the extent to which genetic variance contributes to an individual's risk of epilepsy after an early life insult.</p>
</sec>
</sec>
<sec id="s6">
<title>Inflammatory Preconditioning—Protection <italic>Against</italic> Epilepsy?</title>
<p>Contrary to the above-described literature, there is also preclinical evidence that an early life insult inducing a modest inflammatory response can alternatively attenuate the response to a second-hit insult. This phenomenon, termed “preconditioning,” occurs when the brain develops resistance to injury after exposure to a low dose, typically subthreshold stimuli, such as brief ischemia, hypoxia, or low dose endotoxin. Preconditioning in the context of brain insults has been well documented in adult animals, but less so in the immature brain. Even fewer studies have considered the effect on neuronal excitability and seizure vulnerability.</p>
<p>Administration of a low dose of LPS (typically in the 0.05–1.0 mg/kg range) (<xref ref-type="bibr" rid="B63">Hickey et al., 2011</xref>) is one of the best-characterized approaches to yield neuroprotection <italic>via</italic> preconditioning. Acting <italic>via</italic> TLR4, LPS is thought to reprogram the intracellular response to a subsequent insult, resulting in broad neuroprotection <italic>via</italic> activation of anti-inflammatory factors, alongside the downregulation of NF-κB (<xref ref-type="bibr" rid="B63">Hickey et al., 2011</xref>; <xref ref-type="bibr" rid="B140">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="B2">Amini et al., 2018</xref>). One study compared young rats exposed to systemic low dose LPS at p6 and p30, followed by pilocarpine injection at 2 months of age, and reported that LPS at p30 only resulted in a reduction in acute seizures alongside ameliorated seizure-induced changes in microglial morphology (<xref ref-type="bibr" rid="B79">Kosonowska et al., 2015</xref>). Anti-ictogenic effects have also been reported following TLR3 activation in adult mice, whereby intraventricular poly I:C administered 6 h prior to a KA challenge was found to prevent the anticipated increase in hippocampal excitability (<xref ref-type="bibr" rid="B80">Kostoula et al., 2019</xref>). This effect was mimicked by administration of the cytokine interferon gamma, suggesting that activation of downstream signaling <italic>via</italic> interferon regulatory factor 3 is involved (<xref ref-type="bibr" rid="B80">Kostoula et al., 2019</xref>). Of note, poly I:C administered at 15 min, 1 h, or 24 h prior to KA failed to elicit anti-ictogenic effects, suggesting that the timing is crucial and likely involves the activation of transcriptional rather than posttranslational mechanisms to influence neuronal excitability.</p>
<p>A role for astrocytes in modulating the relative levels of pro- versus anti-inflammatory mediators has been reported as a biological mechanism associated with this phenomenon, as well as microglial priming (<xref ref-type="bibr" rid="B79">Kosonowska et al., 2015</xref>). In addition to modulation of the inflammatory response, several other cellular and molecular mechanisms have been proposed to underlie preconditioning neuroprotection, for example, changes in calcium binding, transcriptional regulation, apoptosis, growth, and development processes (<xref ref-type="bibr" rid="B44">Friedman et al., 2013</xref>; <xref ref-type="bibr" rid="B43">Friedman and Hu, 2014</xref>). The apparent paradox regarding why an early life insult may induce either seizure susceptibility or resistance (alongside neuroprotection) is poorly understood. However, it may be that TLR3 and TLR4 have dual roles whereby activation of alternative pathways in different cell types yields differential consequences. It is clear that the preconditioning phenomenon is both age and dose dependent (<xref ref-type="bibr" rid="B63">Hickey et al., 2011</xref>). Further, the time interval between the first and second insult is likely to be an important determinant. For example, although seizure susceptibility was not examined, one study found that low dose LPS administered at 48 h before HI in p7 rats was neuroprotective, whereas administration earlier at 72 h before HI instead increased the extent of brain damage (<xref ref-type="bibr" rid="B63">Hickey et al., 2011</xref>).</p>
</sec>
<sec id="s7" sec-type="conclusions">
<title>Conclusions</title>
<p>In this review, we have summarized and critically discussed the most common known causes of acquired epilepsy following injury or insult during early life, from maternal infection exposure through to TBI during young childhood. We have excluded from our discussion some other causes of acquired epilepsy, such as brain tumors (<xref ref-type="bibr" rid="B144">Weisman et al., 2018</xref>) or malformation of cortical development (e.g. focal cortical dysplasia) (<xref ref-type="bibr" rid="B23">Crino, 2015</xref>), based on the observation that these factors often persist throughout a patients' life span—rather than being a transient early life insult that resolves with time, in the face of persistent seizure susceptibility, as we have focused on in this review.</p>
<p>All of the described early life insults induce activation of the innate immune response, eliciting reactivity of glial cells, release of pro-inflammatory mediators, and neuronal or network changes in favor of a more excitable CNS microenvironment, which appears to facilitate the process of epileptogenesis and subsequent emergence of spontaneous recurrent seizures (or increased vulnerability to evoked seizures) at a later time (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>). To date, the evidence supports that early life challenges act as risk factors for epilepsy, but do not necessarily cause epilepsy <italic>per se</italic>; indeed, genetic predisposition, environmental factors, and interactions between all of these variables are likely to determine an individual's risk status (<xref ref-type="bibr" rid="B78">Koe et al., 2009</xref>). Experimental models have been invaluable to determine particular developmental windows of increased vulnerability to insult, whereby the brain is rendered immunologically primed and more reactive to a second-hit insult should one occur (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>). Transient cytokine release (including IL-1β, TNFβ, and IL-6; see <xref ref-type="table" rid="T1">
<bold>Table 1</bold>
</xref>), microglial priming, and astrocyte reactivity are all mechanisms by which early life immune challenges can yield long-lasting effects on seizure threshold. Several other cytokines, chemokines, and damage-associated molecular patterns including IL-6 and high mobility group box protein-1 have also been implicated in seizure ictogenesis and epileptogenesis, as reviewed extensively elsewhere (<xref ref-type="bibr" rid="B135">Vezzani et al., 2008</xref>; <xref ref-type="bibr" rid="B133">Vezzani and Viviani, 2015</xref>; <xref ref-type="bibr" rid="B142">Webster et al., 2017</xref>; <xref ref-type="bibr" rid="B138">Vezzani et al., 2019</xref>). However, few studies to date have studied these mediators in the context of how early life immune challenges promote later onset epilepsy.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Key inflammatory mediators implicated in epileptogenesis after early life insults: experimental evidence.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" valign="top">Mediator</th>
<th align="center" colspan="1" rowspan="1" valign="top">Insult</th>
<th align="center" colspan="1" rowspan="1" valign="top">Model</th>
<th align="center" colspan="1" rowspan="1" valign="top">Species/Age</th>
<th align="center" colspan="1" rowspan="1" valign="top">Effect and Potential Mechanisms</th>
<th align="center" colspan="1" rowspan="1" valign="top">Reference(s)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>IL-1β</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bacterial infection (MIA; postnatal infections)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic or intracerebral LPS administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, p14<break></break>Rat, g15–16</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>After p14 LPS, increased IL-1β production in response to KA at adulthood</p></list-item><list-item><p>After LPS + sub-convulsive KA, i.c.v. IL-1β increased the proportion of animals with seizures, while IL-1R antagonist was anticonvulsive</p></list-item><list-item><p>IL-1R modifications associated with hyperexcitability, upregulation of NF-κB, and altered GABAergic subunit expression</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B59">Heida and Pittman, 2005</xref>; <xref ref-type="bibr" rid="B135">Vezzani et al., 2008</xref>; <xref ref-type="bibr" rid="B19">Chen et al., 2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Preterm HI injury</td>
<td align="left" colspan="1" rowspan="1" valign="top">In utero HI + LPS administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, g18</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased placental IL-1β acutely and sub-acutely associated with fetal neuroinflammation and neuronal injury</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B89">Maxwell et al., 2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Viral infection (MIA; postnatal inoculation)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic or intracerebral poly I:C administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, g12–16<break></break>Rat, p13–14</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Chronic epilepsy phenotype in offspring prevented by antibodies to IL-1β and IL-6 (when combined)</p></list-item><list-item><p>Increased IL-1β associated with kindling epileptogenesis</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B50">Galic et al., 2009</xref>; <xref ref-type="bibr" rid="B103">Pineda et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Dupuis et al., 2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile FS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperthermia induction ± intranasal IL-1β</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, p10–12<break></break>Mice, p14–15</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Addition of intranasal IL-1β increased seizures following KA at p70–73, associated with hippocampal cell loss in CA3 region</p></list-item><list-item><p>Hippocampal IL-1β levels only in rats that developed late-onset seizures</p></list-item><list-item><p>Exogenous IL-1β exacerbates FS, while IL-1R–deficient mice show resistance to FS</p></list-item><list-item><p>mRNA levels of IL-1R correlates with epilepsy-predictive MRI signal changes</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B32">Dube et al., 2005</xref>; <xref ref-type="bibr" rid="B34">Dube et al., 2010</xref>; <xref ref-type="bibr" rid="B46">Fukuda et al., 2014</xref>; <xref ref-type="bibr" rid="B47">Fukuda et al., 2015</xref>; <xref ref-type="bibr" rid="B100">Patterson et al., 2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Status epilepticus</td>
<td align="left" colspan="1" rowspan="1" valign="top">KA kindling; lithium-pilocarpine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, p9–15</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Upregulated IL-1β and IL-1R acutely and chronically (to 8 weeks), associated with glial activation</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B64">Holmes and Thompson, 1988</xref>; <xref ref-type="bibr" rid="B112">Rizzi et al., 2003</xref>; <xref ref-type="bibr" rid="B97">Omran et al., 2012</xref>)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Trauma</td>
<td align="left" colspan="1" rowspan="1" valign="top">Controlled cortical impact</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, p21</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Upregulation of IL-1β and IL-1R acutely; prevention of chronic seizure susceptibility by treatment with IL-1R antagonist</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B118">Semple et al., 2017</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>IL-6</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bacterial infection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic or intracerebral LPS administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, p10–14<break></break>Rat, p6</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased IL-6 acutely post-LPS associated with chronically activated microglia</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B79">Kosonowska et al., 2015</xref>)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile FS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperthermia induction ± IL-6 administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, p23–28</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>IL-6 dose-dependently reduced hyperthermia-induced seizures—anticonvulsive effect</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B45">Fukuda et al., 2007</xref>)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Viral infection (MIA)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic or intracerebral poly I:C administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, g12–16</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Chronic epilepsy phenotype in offspring prevented by antibodies to IL-1β and IL-6 (when combined)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B103">Pineda et al., 2013</xref>)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Prenatal immune challenge (IL-6)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic IL-6 administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, g12–16</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>In combination with IL-1β, increased propensity to hippocampal kindling, associated with social deficits</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B141">Washington et al., 2015</xref>)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Status epilepticus</td>
<td align="left" colspan="1" rowspan="1" valign="top">KA kindling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, p9–21</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Upregulated IL-6 acutely after KA, associated with glial activation</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B112">Rizzi et al., 2003</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>TNFα</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bacterial infection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic or intracerebral LPS administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, p6–7, p14</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased TNFα acutely post-LPS, and in response to KA at adulthood</p></list-item><list-item><p>Response to lithium-pilocarpine, KA, and pentylenetetrazol at adulthood was mimicked by i.c.v. recombinant TNFα and blocked by an anti-TNFα antibody</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B49">Galic et al., 2008</xref>; <xref ref-type="bibr" rid="B19">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="B79">Kosonowska et al., 2015</xref>)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Bacterial infection (meningitis)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>S. pneumoniae</italic> inoculation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, p11</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>TNFα-converting enzyme attenuates incidence of seizures and exerts neuroprotection</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B90">Meli et al., 2004</xref>)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Preterm HI</td>
<td align="left" colspan="1" rowspan="1" valign="top">In utero HI + LPS administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, g18</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased placental IL-1β acutely and sub-acutely associated with fetal neuroinflammation and neuronal injury</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B89">Maxwell et al., 2015</xref>)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Status epilepticus</td>
<td align="left" colspan="1" rowspan="1" valign="top">KA kindling; lithium-pilocarpine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat, p9–21<break></break>Rat, p25</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Upregulated TNFα acutely after KA associated with glial activation</p></list-item><list-item><p>Upregulated TNFα and chronically in pilocarpine model of TLE, associated with astrocyte activation</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B112">Rizzi et al., 2003</xref>; <xref ref-type="bibr" rid="B6">Ashhab et al., 2013</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>BBB, blood–brain barrier; DAMP, damage-associated molecular pattern; g, gestational day; GABA, gamma-aminobutyric acid; FS, febrile seizure; HCN, hyperpolarization-activated cyclic nucleotide-gated channel; HI, hypoxic–ischemic injury; HMGB1, high-mobility group box protein-1; HPA, hypothalamic–pituitary axis; i.c.v., intracerebroventricular; IL, interleukin; IL-1R, interleukin-1 receptor; KA, kainic acid; LPS, lipopolysaccharide; mRNA, messenger ribonucleic acid; MIA, maternal immune activation; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NMDA, N-methyl-D-aspartate; NMDAR, N-methyl-D-aspartate receptor; p, postnatal day; poly I:C, polyinosinic:polycytidylic acid; PTZ, pentylenetetrazol; S. pneumoniae, Streptococcus pneumoniae; TBI, traumatic brain injury; TLE, temporal lobe epilepsy; TLR, toll-like receptor; TNFα, tumor necrosis factor alpha.</p>
</table-wrap-foot>
</table-wrap>
<p>Future studies to identify and characterize the key factors mediating the chronic consequences of such insults may allow for the development of predictive tests to more readily identify those individuals at greatest risk. Further, novel immune-based therapies may provide therapeutic benefit by aborting the epileptogenesis process prior to the onset of spontaneous recurrent seizures, or even mitigating its severity after the onset of epilepsy (i.e. disease modifying).</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>BS conceptualized and drafted the manuscript. LD and TO'B provided critical revision and intellectual input, and LD generated the figure. BS and LD incorporated reviewer feedback to revise the manuscript for resubmission. All authors approve the manuscript and are accountable for its content.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The authors acknowledge funding support from the National Health and Medical Research Council of Australia (NHMRC #1122456, 1141347 and 1176426) and Monash University, Australia. </p>
</sec>
<sec id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The reviewer AV declared a past co-authorship with one of the authors, TO'B, to the handling editor.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abraham</surname><given-names>J.</given-names></name><name><surname>Fox</surname><given-names>P. D.</given-names></name><name><surname>Condello</surname><given-names>C.</given-names></name><name><surname>Bartolini</surname><given-names>A.</given-names></name><name><surname>Koh</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures</article-title>. <source/>Neurobiol. Dis.
<volume>46</volume>, <fpage>425</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.02.006</pub-id>
<pub-id pub-id-type="pmid">22366182</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amini</surname><given-names>E.</given-names></name><name><surname>Golpich</surname><given-names>M.</given-names></name><name><surname>Farjam</surname><given-names>A. S.</given-names></name><name><surname>Kamalidehghan</surname><given-names>B.</given-names></name><name><surname>Mohamed</surname><given-names>Z.</given-names></name><name><surname>Ibrahim</surname><given-names>N. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Brain lipopolysaccharide preconditioning-induced gene reprogramming mediates a tolerant state in electroconvulsive shock model of epilepsy</article-title>. <source/>Front. Pharm.
<volume>9</volume>, <fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.3389/fphar.2018.00416</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Annegers</surname><given-names>J. F.</given-names></name><name><surname>Grabow</surname><given-names>J. D.</given-names></name><name><surname>Groover</surname><given-names>R. V.</given-names></name><name><surname>Laws</surname><given-names>E. R.</given-names><suffix>Jr.</suffix></name><name><surname>Elveback</surname><given-names>L. R.</given-names></name><name><surname>Kurland</surname><given-names>L. T.</given-names></name></person-group> (<year>1980</year>). <article-title>Seizures after head trauma: a population study</article-title>. <source/>Neurology
<volume>30</volume>, <fpage>683</fpage>–<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.30.7.683</pub-id>
<pub-id pub-id-type="pmid">7190235</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Annegers</surname><given-names>J. F.</given-names></name><name><surname>Hauser</surname><given-names>W. A.</given-names></name><name><surname>Beghi</surname><given-names>E.</given-names></name><name><surname>Nicolosi</surname><given-names>A.</given-names></name><name><surname>Kurland</surname><given-names>L. T.</given-names></name></person-group> (<year>1988</year>). <article-title>The risk of unprovoked seizures after encephalitis and menigitis</article-title>. <source/>Neurology
<volume>38</volume>, <fpage>1407</fpage>–<lpage>1410</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.38.9.1407</pub-id>
<pub-id pub-id-type="pmid">3412588</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arndt</surname><given-names>D. H.</given-names></name><name><surname>Lerner</surname><given-names>J. T.</given-names></name><name><surname>Matsumoto</surname><given-names>J. H.</given-names></name><name><surname>Madikians</surname><given-names>A.</given-names></name><name><surname>Yudovin</surname><given-names>S.</given-names></name><name><surname>Valino</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Subclinical early posttraumatic seizures detected by continuous EEG monitoring in a consecutive pediatric cohort</article-title>. <source/>Epilepsia
<volume>54</volume>, <fpage>1780</fpage>–<lpage>1788</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12369</pub-id>
<pub-id pub-id-type="pmid">24032982</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ashhab</surname><given-names>M. U.</given-names></name><name><surname>Omran</surname><given-names>A.</given-names></name><name><surname>Kong</surname><given-names>H.</given-names></name><name><surname>Gan</surname><given-names>N.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Expressions of tumor necrosis factor alpha and microRNA-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy</article-title>. <source/>J. Mol. Neurosci.
<volume>51</volume>, <fpage>950</fpage>–<lpage>958</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-013-0013-9</pub-id>
<pub-id pub-id-type="pmid">23636891</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ates</surname><given-names>O.</given-names></name><name><surname>Ondul</surname><given-names>S.</given-names></name><name><surname>Onal</surname><given-names>C.</given-names></name><name><surname>Buyukkiraz</surname><given-names>M.</given-names></name><name><surname>Somay</surname><given-names>H.</given-names></name><name><surname>Cayli</surname><given-names>S. R.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Post-traumatic early epilepsy in pediatric age group with emphasis on influential factors</article-title>. <source/>Childs Nerv. Syst.
<volume>22</volume>, <fpage>279</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1007/s00381-006-0171-y</pub-id>
<pub-id pub-id-type="pmid">15889309</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Auvin</surname><given-names>S.</given-names></name><name><surname>Mazarati</surname><given-names>A.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Sankar</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>a). <article-title>Inflammation enhances epileptogenesis in the developing rat brain</article-title>. <source/>Neurobiol. Dis.
<volume>40</volume>, <fpage>303</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.06.004</pub-id>
<pub-id pub-id-type="pmid">20600912</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Auvin</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Mazarati</surname><given-names>A.</given-names></name><name><surname>Sankar</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>b). <article-title>Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA</article-title>. <source/>Epilepsia
<volume>51</volume>, <fpage>34</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02606.x</pub-id>
<pub-id pub-id-type="pmid">20618397</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Becker</surname><given-names>A. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Review: animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis</article-title>. <source/>Neuropathol. Appl. Neurobiol.
<volume>44</volume>, <fpage>112</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1111/nan.12451</pub-id>
<pub-id pub-id-type="pmid">29130506</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name></person-group> (<year>2002</year>). <article-title>Excitatory actions of gaba during development: the nature of the nurture</article-title>. <source/>Nat. Rev. Neurosci.
<volume>3</volume>, <fpage>728</fpage>–<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1038/nrn920</pub-id>
<pub-id pub-id-type="pmid">12209121</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berg</surname><given-names>A. T.</given-names></name><name><surname>Shinnar</surname><given-names>S.</given-names></name></person-group> (<year>1996</year>). <article-title>Unprovoked seizures in children with febrile seizures: short-term outcome</article-title>. <source/>Neurology
<volume>1996</volume>, <fpage>562</fpage>–<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.47.2.562</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bilbo</surname><given-names>S. D.</given-names></name><name><surname>Schwarz</surname><given-names>J. M.</given-names></name></person-group> (<year>2012</year>). <article-title>The immune system and developmental programming of brain and behavior</article-title>. <source/>Front. Neuroendocrinol.
<volume>33</volume>, <fpage>267</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2012.08.006</pub-id>
<pub-id pub-id-type="pmid">22982535</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bjorkman</surname><given-names>S. T.</given-names></name><name><surname>Miller</surname><given-names>S. M.</given-names></name><name><surname>Rose</surname><given-names>S. E.</given-names></name><name><surname>Burke</surname><given-names>C.</given-names></name><name><surname>Colditz</surname><given-names>P. B.</given-names></name></person-group> (<year>2010</year>). <article-title>Seizures are associated with brain injury severity in a neonatal model of hypoxia-ischemia</article-title>. <source/>Neuroscience
<volume>166</volume>, <fpage>157</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.11.067</pub-id>
<pub-id pub-id-type="pmid">20006975</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bolkvadze</surname><given-names>T.</given-names></name><name><surname>Pitkanen</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse</article-title>. <source/>J. Neurotrauma
<volume>29</volume>, <fpage>789</fpage>–<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2011.1954</pub-id>
<pub-id pub-id-type="pmid">22023672</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brima</surname><given-names>T.</given-names></name><name><surname>Otahal</surname><given-names>J.</given-names></name><name><surname>Mares</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Increased susceptibility to pentetrazol-induced seizures in developing rats after cortical photothrombotic ischemic stroke at P7</article-title>. <source/>Brain Res.
<volume>1507</volume>, <fpage>146</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2013.02.037</pub-id>
<pub-id pub-id-type="pmid">23454234</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Baram</surname><given-names>T. Z.</given-names></name><name><surname>Soltesz</surname><given-names>I.</given-names></name></person-group> (<year>1999</year>). <article-title>Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits</article-title>. <source/>Nat. Med.
<volume>5</volume>, <fpage>888</fpage>–<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1038/11330</pub-id>
<pub-id pub-id-type="pmid">10426311</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. J.</given-names></name><name><surname>Fang</surname><given-names>P. C.</given-names></name><name><surname>Chow</surname><given-names>J. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Clinical characteristics and prognostic factors of postencephalitic epilepsy in children</article-title>. <source/>J. Child Neurol.
<volume>21</volume>, <fpage>1047</fpage>–<lpage>1051</lpage>. <pub-id pub-id-type="doi">10.1177/7010.2006.00223</pub-id>
<pub-id pub-id-type="pmid">17156696</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. H.</given-names></name><name><surname>Kuo</surname><given-names>T. T.</given-names></name><name><surname>Chu</surname><given-names>M. T.</given-names></name><name><surname>Ma</surname><given-names>H. I.</given-names></name><name><surname>Chiang</surname><given-names>Y. H.</given-names></name><name><surname>Huang</surname><given-names>E. Y. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Postnatal systemic inflammation exacerbates impairment of hippocampal synaptic plasticity in an animal seizure model</article-title>. <source/>Neuroimmunomodulation
<volume>20</volume>, <fpage>223</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1159/000348440</pub-id>
<pub-id pub-id-type="pmid">23736043</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Christensen</surname><given-names>J.</given-names></name><name><surname>Pedersen</surname><given-names>M. G.</given-names></name><name><surname>Pedersen</surname><given-names>C. B.</given-names></name><name><surname>Sidenius</surname><given-names>P.</given-names></name><name><surname>Olsen</surname><given-names>J.</given-names></name><name><surname>Vestergaard</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study</article-title>. <source/>Lancet
<volume>373</volume>, <fpage>1105</fpage>–<lpage>1110</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(09)60214-2</pub-id>
<pub-id pub-id-type="pmid">19233461</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Clarke</surname><given-names>L. E.</given-names></name><name><surname>Barres</surname><given-names>B. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Emerging roles of astrocytes in neural circuit development</article-title>. <source/>Nat. Rev. Neurosci.
<volume>14</volume>, <fpage>311</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3484</pub-id>
<pub-id pub-id-type="pmid">23595014</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corradini</surname><given-names>I.</given-names></name><name><surname>Focchi</surname><given-names>E.</given-names></name><name><surname>Rasile</surname><given-names>M.</given-names></name><name><surname>Morini</surname><given-names>R.</given-names></name><name><surname>Desiato</surname><given-names>G.</given-names></name><name><surname>Tomasoni</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Maternal immune activation delays excitatory-to-inhibitory gamma-aminobutyric acid switch in offspring</article-title>. <source/>Biol. Psychiatry
<volume>83</volume>, <fpage>680</fpage>–<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.09.030</pub-id>
<pub-id pub-id-type="pmid">29146047</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crino</surname><given-names>P. B.</given-names></name></person-group> (<year>2015</year>). <article-title>mTOR signaling in epilepsy: insights from malformations of cortical development</article-title>. <source/>Cold Spring Harb. Perspect. Med.
<volume>1</volume>, <fpage>4</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a022442</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>D'ambrosio</surname><given-names>R.</given-names></name><name><surname>Fairbanks</surname><given-names>J. P.</given-names></name><name><surname>Fender</surname><given-names>J. S.</given-names></name><name><surname>Born</surname><given-names>D. E.</given-names></name><name><surname>Doyle</surname><given-names>D. L.</given-names></name><name><surname>Miller</surname><given-names>J. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Post-traumatic epilepsy following fluid percussion injury in the rat</article-title>. <source/>Brain
<volume>127</volume>, <fpage>304</fpage>–<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awh038</pub-id>
<pub-id pub-id-type="pmid">14607786</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dahlgren</surname><given-names>J.</given-names></name><name><surname>Samuelsson</surname><given-names>A. M.</given-names></name><name><surname>Jansson</surname><given-names>T.</given-names></name><name><surname>Holmang</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation</article-title>. <source/>Pediatr. Res.
<volume>60</volume>, <fpage>147</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1203/01.pdr.0000230026.74139.18</pub-id>
<pub-id pub-id-type="pmid">16864694</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Lanerolle</surname><given-names>N. C.</given-names></name><name><surname>Lee</surname><given-names>T. S.</given-names></name><name><surname>Spencer</surname><given-names>D. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Astrocytes and epilepsy</article-title>. <source/>Neurotherapeutics
<volume>7</volume>, <fpage>424</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1016/j.nurt.2010.08.002</pub-id>
<pub-id pub-id-type="pmid">20880506</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Vries</surname><given-names>E.</given-names></name><name><surname>Van Den Munckhof</surname><given-names>B.</given-names></name><name><surname>Braun</surname><given-names>K.</given-names></name><name><surname>Van Royen-Kerkhof</surname><given-names>A.</given-names></name><name><surname>De Jager</surname><given-names>W.</given-names></name><name><surname>Jansen</surname><given-names>F. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Inflammatory mediators in human epilepsy: a systematic review and meta-analysis</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>63</volume>, <fpage>177</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.02.007</pub-id>
<pub-id pub-id-type="pmid">26877106</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diamond</surname><given-names>M. L.</given-names></name><name><surname>Ritter</surname><given-names>A. C.</given-names></name><name><surname>Failla</surname><given-names>M. D.</given-names></name><name><surname>Boles</surname><given-names>J. A.</given-names></name><name><surname>Conley</surname><given-names>Y. P.</given-names></name><name><surname>Kochanek</surname><given-names>P. M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>IL-1beta associations with posttraumatic epilepsy development: a genetics and biomarker cohort study</article-title>. <source/>Epilepsia
<volume>56</volume>, <fpage>991</fpage>–<lpage>1001</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13100</pub-id>
<pub-id pub-id-type="pmid">26149793</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dilena</surname><given-names>R.</given-names></name><name><surname>Mauri</surname><given-names>E.</given-names></name><name><surname>Aronica</surname><given-names>E.</given-names></name><name><surname>Bernasconi</surname><given-names>P.</given-names></name><name><surname>Bana</surname><given-names>C.</given-names></name><name><surname>Cappelletti</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome</article-title>. <source/>Epilepsia Open
<volume>4</volume>, <fpage>344</fpage>–<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1002/epi4.12317</pub-id>
<pub-id pub-id-type="pmid">31168503</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Disabato</surname><given-names>D.</given-names></name><name><surname>Quan</surname><given-names>N.</given-names></name><name><surname>Godbout</surname><given-names>J. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuroinflammation: the devil is in the details</article-title>. <source/>J. Neurochem.
<volume>139</volume>, <fpage>136</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13607</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dube</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Eghbal-Ahmadi</surname><given-names>M.</given-names></name><name><surname>Brunson</surname><given-names>K.</given-names></name><name><surname>Soltesz</surname><given-names>I.</given-names></name><name><surname>Baram</surname><given-names>T. Z.</given-names></name></person-group> (<year>2000</year>). <article-title>Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long term</article-title>. <source/>Ann. Neurol.
<volume>47</volume>, <fpage>336</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1002/1531-8249(200003)47:3&lt;336::AID-ANA9&gt;3.0.CO;2-W</pub-id>
<pub-id pub-id-type="pmid">10716253</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dube</surname><given-names>C.</given-names></name><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Behrens</surname><given-names>M.</given-names></name><name><surname>Bartfai</surname><given-names>T.</given-names></name><name><surname>Baram</surname><given-names>T. Z.</given-names></name></person-group> (<year>2005</year>). <article-title>Interleukin-1beta contributes to the generation of experimental febrile seizures</article-title>. <source/>Ann. Neurol.
<volume>57</volume>, <fpage>152</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20358</pub-id>
<pub-id pub-id-type="pmid">15622539</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dube</surname><given-names>C.</given-names></name><name><surname>Brewster</surname><given-names>A. L.</given-names></name><name><surname>Richichi</surname><given-names>C.</given-names></name><name><surname>Zha</surname><given-names>Q.</given-names></name><name><surname>Baram</surname><given-names>T. Z.</given-names></name></person-group> (<year>2007</year>). <article-title>Fever, febrile seizures and epilepsy</article-title>. <source/>Trends Neurosci.
<volume>30</volume>, <fpage>490</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2007.07.006</pub-id>
<pub-id pub-id-type="pmid">17897728</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dube</surname><given-names>C. M.</given-names></name><name><surname>Ravizza</surname><given-names>T.</given-names></name><name><surname>Hamamura</surname><given-names>M.</given-names></name><name><surname>Zha</surname><given-names>Q.</given-names></name><name><surname>Keebaugh</surname><given-names>A.</given-names></name><name><surname>Fok</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>7484</fpage>–<lpage>7494</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0551-10.2010</pub-id>
<pub-id pub-id-type="pmid">20519523</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dupuis</surname><given-names>N.</given-names></name><name><surname>Mazarati</surname><given-names>A.</given-names></name><name><surname>Denous</surname><given-names>B.</given-names></name><name><surname>Chhor</surname><given-names>V.</given-names></name><name><surname>Fleiss</surname><given-names>B.</given-names></name><name><surname>Le Charpentier</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Pro-epileptogenic effects of viral-like inflammation in both mature and immature brains</article-title>. <source/>J. Neuroinflam.
<volume>13</volume>, <fpage>307</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-016-0773-6</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Engel</surname><given-names>J.</given-names><suffix>Jr.</suffix></name></person-group> (<year>1996</year>). <article-title>Introduction to temporal lobe epilepsy</article-title>. <source/>Epilepsy Res.
<volume>26</volume>, <fpage>141</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/S0920-1211(96)00043-5</pub-id>
<pub-id pub-id-type="pmid">8985696</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>H.</given-names></name><name><surname>Wirdefeldt</surname><given-names>K.</given-names></name><name><surname>Asberg</surname><given-names>S.</given-names></name><name><surname>Zelano</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Family history increases the risk of late seizures after stroke</article-title>. <source/>Neurology. <volume>93</volume>, <fpage>e1964</fpage>–<lpage>1970</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000008522</pub-id>
<pub-id pub-id-type="pmid">31645466</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eun</surname><given-names>B. L.</given-names></name><name><surname>Abraham</surname><given-names>J.</given-names></name><name><surname>Mlsna</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>M. J.</given-names></name><name><surname>Koh</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Lipopolysaccharide potentiates hyperthermia-induced seizures</article-title>. <source/>Brain Behav.
<volume>5</volume>, <fpage>e00348</fpage>. <pub-id pub-id-type="doi">10.1002/brb3.348</pub-id>
<pub-id pub-id-type="pmid">26357586</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Farina</surname><given-names>C.</given-names></name><name><surname>Aloisi</surname><given-names>F.</given-names></name><name><surname>Meinl</surname><given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>Astrocytes are active players in cerebral innate immunity</article-title>. <source/>Trends Immunol.
<volume>28</volume>, <fpage>138</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2007.01.005</pub-id>
<pub-id pub-id-type="pmid">17276138</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feng</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name></person-group> (<year>2016</year>). <article-title>Generation of febrile seizures and subsequent epileptogenesis</article-title>. <source/>Neurosci. Bull.
<volume>32</volume>, <fpage>481</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-016-0054-5</pub-id>
<pub-id pub-id-type="pmid">27562688</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feng</surname><given-names>B.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Dai</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Transient increase of interleukin-1beta after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>21931</fpage>. <pub-id pub-id-type="doi">10.1038/srep21931</pub-id>
<pub-id pub-id-type="pmid">26902320</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frank</surname><given-names>M. G.</given-names></name><name><surname>Hershman</surname><given-names>S. A.</given-names></name><name><surname>Weber</surname><given-names>M. D.</given-names></name><name><surname>Watkins</surname><given-names>L. R.</given-names></name><name><surname>Maier</surname><given-names>S. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Chronic exposure to exogenous glucocorticoids primes microglia to pro-inflammatory stimuli and induces NLRP3 mRNA in the hippocampus</article-title>. <source/>Psychoneuroendocrinology
<volume>40</volume>, <fpage>191</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2013.11.006</pub-id>
<pub-id pub-id-type="pmid">24485491</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friedman</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Early-life seizures in predisposing neuronal preconditioning: a critical review</article-title>. <source/>Life Sci.
<volume>94</volume>, <fpage>92</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2013.11.003</pub-id>
<pub-id pub-id-type="pmid">24239642</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friedman</surname><given-names>L. K.</given-names></name><name><surname>Mancuso</surname><given-names>J.</given-names></name><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Kudur</surname><given-names>V.</given-names></name><name><surname>Leheste</surname><given-names>J. R.</given-names></name><name><surname>Iacobas</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Transcriptome profiling of hippocampal CA1 after early-life seizure-induced preconditioning may elucidate new genetic therapies for epilepsy</article-title>. <source/>Eur. J. Neurosci.
<volume>38</volume>, <fpage>2139</fpage>–<lpage>2152</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12168</pub-id>
<pub-id pub-id-type="pmid">23551718</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>M.</given-names></name><name><surname>Morimoto</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Shinonaga</surname><given-names>C.</given-names></name><name><surname>Ishida</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Interleukin-6 attenuates hyperthermia-induced seizures in developing rats</article-title>. <source/>Brain Dev.
<volume>29</volume>, <fpage>644</fpage>–<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2007.04.007</pub-id>
<pub-id pub-id-type="pmid">17553644</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>M.</given-names></name><name><surname>Hino</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Morimoto</surname><given-names>T.</given-names></name><name><surname>Ishii</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Postnatal interleukin-1beta enhances adulthood seizure susceptibility and neuronal cell death after prolonged experimental febrile seizures in infantile rats</article-title>. <source/>Acta Neurol. Belg.
<volume>114</volume>, <fpage>179</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1007/s13760-013-0246-y</pub-id>
<pub-id pub-id-type="pmid">24002650</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>M.</given-names></name><name><surname>Ito</surname><given-names>M.</given-names></name><name><surname>Yano</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Motoie</surname><given-names>R.</given-names></name><name><surname>Yano</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Postnatal interleukin-1β administration after experimental prolonged febrile seizures enhances epileptogenesis in adulthood</article-title>. <source/>Metab. Brain Dis.
<volume>30</volume>, <fpage>813</fpage>–<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-014-9648-7</pub-id>
<pub-id pub-id-type="pmid">25575695</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>M.</given-names></name><name><surname>Tsukahara</surname><given-names>T.</given-names></name><name><surname>Tomita</surname><given-names>K.</given-names></name><name><surname>Iwai</surname><given-names>H.</given-names></name><name><surname>Sonomura</surname><given-names>T.</given-names></name><name><surname>Miyawaki</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Neonatal maternal separation delays the GABA excitatory-to-inhibitory functional switch by inhibiting KCC2 expression</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>493</volume>, <fpage>1243</fpage>–<lpage>1249</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.09.143</pub-id>
<pub-id pub-id-type="pmid">28962859</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galic</surname><given-names>M. A.</given-names></name><name><surname>Riazi</surname><given-names>K.</given-names></name><name><surname>Heida</surname><given-names>J. G.</given-names></name><name><surname>Mouihate</surname><given-names>A.</given-names></name><name><surname>Fournier</surname><given-names>N. M.</given-names></name><name><surname>Spencer</surname><given-names>S. J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Postnatal inflammation increases seizure susceptibility in adult rats</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>6904</fpage>–<lpage>6913</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1901-08.2008</pub-id>
<pub-id pub-id-type="pmid">18596165</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galic</surname><given-names>M. A.</given-names></name><name><surname>Riazi</surname><given-names>K.</given-names></name><name><surname>Henderson</surname><given-names>A. K.</given-names></name><name><surname>Tsutsui</surname><given-names>S.</given-names></name><name><surname>Pittman</surname><given-names>Q. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats</article-title>. <source/>Neurobiol. Dis.
<volume>36</volume>, <fpage>343</fpage>–<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2009.07.025</pub-id>
<pub-id pub-id-type="pmid">19660546</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Ren</surname><given-names>W.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>Acute lipopolysaccharide exposure facilitates epileptiform activity via enhanced excitatory synaptic transmission and neuronal excitability <italic>in vitro</italic>
</article-title>. <source/>Neuropsychatr. Dis. Treat
<volume>10</volume>, <fpage>1489</fpage>–<lpage>1495</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S65695</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilmore</surname><given-names>J. H.</given-names></name><name><surname>Jarskog</surname><given-names>L. F.</given-names></name><name><surname>Vadlamudi</surname><given-names>M. S.</given-names></name></person-group> (<year>2005</year>). <article-title>Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat</article-title>. <source/>J. Neuroimmunol.
<volume>159</volume>, <fpage>106</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2004.10.008</pub-id>
<pub-id pub-id-type="pmid">15652408</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glass</surname><given-names>H. C.</given-names></name><name><surname>Hong</surname><given-names>K. J.</given-names></name><name><surname>Rogers</surname><given-names>E. E. E. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Risk factors for epilepsy in children with neonatal encephalopathy</article-title>. <source/>Pediatr. Res.
<volume>70</volume>, <fpage>535</fpage>–<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e31822f24c7</pub-id>
<pub-id pub-id-type="pmid">21796017</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gottlieb</surname><given-names>A.</given-names></name><name><surname>Keydar</surname><given-names>I.</given-names></name><name><surname>Epstein</surname><given-names>H. T.</given-names></name></person-group> (<year>1977</year>). <article-title>Rodent brain growth stages: an analytical review</article-title>. <source/>Biol. Neonate
<volume>32</volume>, <fpage>166</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1159/000241012</pub-id>
<pub-id pub-id-type="pmid">603801</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gross</surname><given-names>A.</given-names></name><name><surname>Benninger</surname><given-names>F.</given-names></name><name><surname>Madar</surname><given-names>R.</given-names></name><name><surname>Illouz</surname><given-names>T.</given-names></name><name><surname>Griffioen</surname><given-names>K.</given-names></name><name><surname>Steiner</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Toll-like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of SE-induced epilepsy in mice</article-title>. <source/>Epilepsia
<volume>58</volume>, <fpage>586</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13688</pub-id>
<pub-id pub-id-type="pmid">28166388</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gullo</surname><given-names>F.</given-names></name><name><surname>Amadeo</surname><given-names>A.</given-names></name><name><surname>Donvito</surname><given-names>G.</given-names></name><name><surname>Lecchi</surname><given-names>M.</given-names></name><name><surname>Costa</surname><given-names>B.</given-names></name><name><surname>Constanti</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Atypical “seizure-like” activity in cortical reverberating networks <italic>in vitro</italic> can be caused by LPS-induced inflammation: a multi-electrode array study from a hundred neurons</article-title>. <source/>Front. Cell Neurosci.
<volume>8</volume>, <elocation-id>361</elocation-id>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00361</pub-id>
<pub-id pub-id-type="pmid">25404893</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guma</surname><given-names>E.</given-names></name><name><surname>Plitman</surname><given-names>E.</given-names></name><name><surname>Chakravarty</surname><given-names>M. M.</given-names></name></person-group> (<year>2019</year>). <article-title>The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: a translational review of neuroimaging studies with implications for autism spectrum disorder and schizophrenia</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>104</volume>, <fpage>141</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2019.06.020</pub-id>
<pub-id pub-id-type="pmid">31265870</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hauser</surname><given-names>W. A.</given-names></name></person-group> (<year>1995</year>). <article-title>Epidemiology of epilepsy in children</article-title>. <source/>Neurosurg. Clin. N. Am.
<volume>6</volume>, <fpage>419</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1016/S1042-3680(18)30437-6</pub-id>
<pub-id pub-id-type="pmid">7670316</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heida</surname><given-names>J. G.</given-names></name><name><surname>Pittman</surname><given-names>Q. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Causal links between brain cytokines and experimental febrile convulsions in the rat</article-title>. <source/>Epilepsia
<volume>46</volume>, <fpage>1906</fpage>–<lpage>1913</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2005.00294.x</pub-id>
<pub-id pub-id-type="pmid">16393156</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heida</surname><given-names>J. G.</given-names></name><name><surname>Boisse</surname><given-names>L.</given-names></name><name><surname>Pittman</surname><given-names>Q. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Lipopolysaccharide-induced febrile convulsions in the rat: short-term sequelae</article-title>. <source/>Epilepsia
<volume>45</volume>, <fpage>1317</fpage>–<lpage>1329</lpage>. <pub-id pub-id-type="doi">10.1111/j.0013-9580.2004.13704.x</pub-id>
<pub-id pub-id-type="pmid">15509232</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Herlenius</surname><given-names>E.</given-names></name><name><surname>Lagercrantz</surname><given-names>H.</given-names></name></person-group> (<year>2004</year>). <article-title>Development of neurotransmitter systems during critical periods</article-title>. <source/>Exp. Neurol.
<volume>190</volume>, <fpage>8</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2004.03.027</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Herman</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Epilepsy after brain insult: targeting epileptogenesis</article-title>. <source/>Neurology
<volume>59</volume>, <fpage>S21</fpage>–<lpage>S26</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.59.9_suppl_5.S21</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hickey</surname><given-names>E.</given-names></name><name><surname>Shi</surname><given-names>H.</given-names></name><name><surname>Van Arsdell</surname><given-names>G.</given-names></name><name><surname>Askalan</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Lipopolysaccharide-induced preconditioning against ischemic injury is associated with changes in toll-like receptor 4 expression in the rat developing brain</article-title>. <source/>Pediatr. Res.
<volume>70</volume>, <fpage>10</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e31821d02aa</pub-id>
<pub-id pub-id-type="pmid">21659958</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holmes</surname><given-names>G. L.</given-names></name><name><surname>Thompson</surname><given-names>J. L.</given-names></name></person-group> (<year>1988</year>). <article-title>Effects of kainic acid on seizure susceptibility in the developing brain</article-title>. <source/>Brain Res.
<volume>467</volume>, <fpage>51</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/0165-3806(88)90066-1</pub-id>
<pub-id pub-id-type="pmid">3359330</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>C. C.</given-names></name><name><surname>Chang</surname><given-names>Y. C.</given-names></name></person-group> (<year>2009</year>). <article-title>The long-term effects of febrile seizures on the hippocampal neuronal plasticity - clinical and experimental evidence</article-title>. <source/>Brain Dev.
<volume>31</volume>, <fpage>383</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2008.11.008</pub-id>
<pub-id pub-id-type="pmid">19131199</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Janeczko</surname><given-names>K.</given-names></name><name><surname>Kosonowska</surname><given-names>E.</given-names></name><name><surname>Kiepura</surname><given-names>A.</given-names></name><name><surname>Weglarz</surname><given-names>W.</given-names></name><name><surname>Setkowicz</surname><given-names>Z.</given-names></name></person-group> (<year>2018</year>). <article-title>Volumetric response of the adult brain to seizures depends on the developmental stage when systemic inflammation was induced</article-title>. <source/>Epilepsy Behav.
<volume>78</volume>, <fpage>280</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2017.09.009</pub-id>
<pub-id pub-id-type="pmid">29128467</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jensen</surname><given-names>F. E.</given-names></name><name><surname>Baram</surname><given-names>T. Z.</given-names></name></person-group> (<year>2000</year>). <article-title>Developmental seizures induced by common early-life insults: short- and long-term effects on seizure susceptibility</article-title>. <source/>Ment. Retard. Dev. Disabil.
<volume>6</volume>, <fpage>253</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1002/1098-2779(2000)6:4&lt;253::AID-MRDD4&gt;3.0.CO;2-P</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jensen</surname><given-names>F. E.</given-names></name><name><surname>Applegate</surname><given-names>C. D.</given-names></name><name><surname>Holtzman</surname><given-names>D.</given-names></name><name><surname>Belin</surname><given-names>T.</given-names></name><name><surname>Burchfiel</surname><given-names>J.</given-names></name></person-group> (<year>1991</year>). <article-title>Epileptogenic effects of hypoxia on immature rodent brain</article-title>. <source/>Ann. Neurol.
<volume>29</volume>, <fpage>629</fpage>–<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410290610</pub-id>
<pub-id pub-id-type="pmid">1909851</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jensen</surname><given-names>F. E.</given-names></name><name><surname>Holmes</surname><given-names>G. H.</given-names></name><name><surname>Lombroso</surname><given-names>C. T.</given-names></name><name><surname>Blume</surname><given-names>H. K.</given-names></name><name><surname>Firkusny</surname><given-names>I.</given-names></name></person-group> (<year>1992</year>). <article-title>Age dependent long term changes in seizure susceptibility and neurobehavior following hypoxia in the rat</article-title>. <source/>Epilepsia
<volume>33</volume>, <fpage>971</fpage>–<lpage>980</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1157.1992.tb01746.x</pub-id>
<pub-id pub-id-type="pmid">1464280</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jensen</surname><given-names>F. E.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Stafstrom</surname><given-names>C. E.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Geary</surname><given-names>C.</given-names></name><name><surname>Stevens</surname><given-names>M. C.</given-names></name></person-group> (<year>1998</year>). <article-title>Acute and chronic increases in excitability in rat hippocampal slices after perinatal hypoxia <italic>in vivo</italic>
</article-title>. <source/>J. Neurophysiol.
<volume>79</volume>, <fpage>73</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1998.79.1.73</pub-id>
<pub-id pub-id-type="pmid">9425178</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>N. C.</given-names></name><name><surname>O'brien</surname><given-names>T. J.</given-names></name><name><surname>Carmant</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Interaction between sex and early-life stress: influence on epileptogenesis and epilepsy comorbidities</article-title>. <source/>Neurobiol. Dis.
<volume>72</volume>, <fpage>233</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.09.004</pub-id>
<pub-id pub-id-type="pmid">25266701</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kadam</surname><given-names>S. D.</given-names></name><name><surname>White</surname><given-names>A. M.</given-names></name><name><surname>Staley</surname><given-names>K. J.</given-names></name><name><surname>Dudek</surname><given-names>F. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Continuous electroencephalographic monitoring with radio-telemetry in a rat model of perinatal hypoxia–ischemia reveals progressive post-stroke epilepsy</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>404</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4093-09.2010</pub-id>
<pub-id pub-id-type="pmid">20053921</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kelly</surname><given-names>K. M.</given-names></name><name><surname>Miller</surname><given-names>E. R.</given-names></name><name><surname>Lepsveridze</surname><given-names>E.</given-names></name><name><surname>Kharlamov</surname><given-names>E. A.</given-names></name><name><surname>Mchedlishvili</surname><given-names>Z.</given-names></name></person-group> (<year>2015</year>). <article-title>Posttraumatic seizures and epilepsy in adult rats after controlled cortical impact</article-title>. <source/>Epilepsy Res.
<volume>117</volume>, <fpage>104</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2015.09.009</pub-id>
<pub-id pub-id-type="pmid">26432760</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kenney-Jung</surname><given-names>D. L.</given-names></name><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Kahoud</surname><given-names>R. J.</given-names></name><name><surname>Lafrance-Corey</surname><given-names>R. G.</given-names></name><name><surname>Ho</surname><given-names>M. L.</given-names></name><name><surname>Muskardin</surname><given-names>T. W.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Febrile infection-related epilepsy syndrome treated with anakinra</article-title>. <source/>Ann. Neurol.
<volume>80</volume>, <fpage>939</fpage>–<lpage>945</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24806</pub-id>
<pub-id pub-id-type="pmid">27770579</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>I. D.</given-names></name><name><surname>Mlsna</surname><given-names>L. M.</given-names></name><name><surname>Yoon</surname><given-names>S.</given-names></name><name><surname>Le</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A postnatal peak in microglial development in the mouse hippocampus is correlated with heightened sensitivity to seizure triggers</article-title>. <source/>Brain Behav.
<volume>5</volume>, <fpage>e00403</fpage>. <pub-id pub-id-type="doi">10.1002/brb3.403</pub-id>
<pub-id pub-id-type="pmid">26807334</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kira</surname><given-names>K.</given-names></name><name><surname>Torisu</surname><given-names>H.</given-names></name><name><surname>Takemoto</surname><given-names>M.</given-names></name><name><surname>Nomura</surname><given-names>A.</given-names></name><name><surname>Sakai</surname><given-names>Y.</given-names></name><name><surname>Sanefuji</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Genetic susceptibility to simple febrile seizures: interleukin-1β promoter polymorphisms are associated with sporadic cases</article-title>. <source/>Neurosci. Lett.
<volume>384</volume>, <fpage>239</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2005.04.097</pub-id>
<pub-id pub-id-type="pmid">15916853</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klioueva</surname><given-names>L. A.</given-names></name><name><surname>Van Luijtelaar</surname><given-names>E. L.</given-names></name><name><surname>Chepurnova</surname><given-names>N. E.</given-names></name><name><surname>Chepurnov</surname><given-names>S. A.</given-names></name></person-group> (<year>2001</year>). <article-title>PTZ-induce seizures in rats: effects of age and strain</article-title>. <source/>Physiol. Behav.
<volume>72</volume>, <fpage>421</fpage>–<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9384(00)00425-X</pub-id>
<pub-id pub-id-type="pmid">11274687</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koe</surname><given-names>A. S.</given-names></name><name><surname>Jones</surname><given-names>N. C.</given-names></name><name><surname>Salzberg</surname><given-names>M. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Early life stress as an influence on limbic epilepsy: an hypothesis whose time has come?</article-title>
<source/>Front. Behav. Neurosci. <volume>3</volume>, <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.3389/neuro.08.024.2009</pub-id>
<pub-id pub-id-type="pmid">19194528</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kosonowska</surname><given-names>E.</given-names></name><name><surname>Janeczko</surname><given-names>K.</given-names></name><name><surname>Setkowicz</surname><given-names>Z.</given-names></name></person-group> (<year>2015</year>). <article-title>Inflammation induced at different developmental stages affects differently the range of microglial reactivity and the course of seizures evoked in the adult rat</article-title>. <source/>Epilepsy Beh.
<volume>49</volume>, <fpage>66</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2015.04.063</pub-id>
</mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kostoula</surname><given-names>C.</given-names></name><name><surname>Shaker</surname><given-names>T.</given-names></name><name><surname>Cerovic</surname><given-names>M.</given-names></name><name><surname>Craparotta</surname><given-names>I.</given-names></name><name><surname>Marchini</surname><given-names>S.</given-names></name><name><surname>Butti</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>TLR3 preconditioning induces anti-inflammatory and anti-ictogenic effects in mice mediated by the IRF3/IFN-beta axis</article-title>. <source/>Brain Behav. Immun. <volume>81</volume>, <fpage>598</fpage>–<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2019.07.021</pub-id>
<pub-id pub-id-type="pmid">31336144</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kumar</surname><given-names>G.</given-names></name><name><surname>Jones</surname><given-names>N. C.</given-names></name><name><surname>Morris</surname><given-names>M. J.</given-names></name><name><surname>Rees</surname><given-names>S.</given-names></name><name><surname>O'brien</surname><given-names>T. J.</given-names></name><name><surname>Salzberg</surname><given-names>M. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Early life stress enhancement of limbic epileptogenesis in adult rats: mechanistic insights</article-title>. <source/>PloS One
<volume>6</volume>, <fpage>e24033</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0024033</pub-id>
<pub-id pub-id-type="pmid">21957442</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lenz</surname><given-names>K. M.</given-names></name><name><surname>Nelson</surname><given-names>L. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglia and beyond: innate immune cells as regulators of brain development and behavioral function</article-title>. <source/>Front. Immunol.
<volume>9</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00698</pub-id>
<pub-id pub-id-type="pmid">29403488</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leung</surname><given-names>W. L.</given-names></name><name><surname>Casillas-Espinosa</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Perucca</surname><given-names>P.</given-names></name><name><surname>Powell</surname><given-names>K.</given-names></name><name><surname>O'brien</surname><given-names>T. J.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>An animal model of genetic predisposition to develop acquired epileptogenesis: The FAST and SLOW rats</article-title>. <source/>Epilepsia
<volume>60</volume>, <fpage>2023</fpage>–<lpage>2036</lpage>. <pub-id pub-id-type="doi">10.1111/epi.16329</pub-id>
<pub-id pub-id-type="pmid">31468516</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lothman</surname><given-names>E. W.</given-names></name><name><surname>Bertram</surname><given-names>E. H.</given-names><suffix>3rd</suffix></name></person-group> (<year>1993</year>). <article-title>Epileptogenic effects of status epilepticus</article-title>. <source/>Epilepsia
<volume>34</volume>
<issue>Suppl;1</issue>, <fpage>S59</fpage>–<lpage>S70</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1157.1993.tb05907.x</pub-id>
<pub-id pub-id-type="pmid">8462492</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lowenstein</surname><given-names>D. H.</given-names></name></person-group> (<year>1996</year>). <article-title>Recent advances related to basic mechanisms of epileptogenesis</article-title>. <source/>Epilepsy Res.
<volume>Suppl 11</volume>, <fpage>45</fpage>–<lpage>60</lpage>.</mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>W. D.</given-names></name><name><surname>Min</surname><given-names>J. W.</given-names></name><name><surname>Huang</surname><given-names>W. X.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Peng</surname><given-names>Y. Y.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1</article-title>. <source/>J. Neuroinflammation
<volume>15</volume>, <fpage>186</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-018-1221-6</pub-id>
<pub-id pub-id-type="pmid">29925377</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lynch</surname><given-names>J. K.</given-names></name><name><surname>Nelson</surname><given-names>K. B.</given-names></name></person-group> (<year>2001</year>). <article-title>Epidemiology of perinatal stroke</article-title>. <source/>Curr. Opin. Pediatr.
<volume>13</volume>, <fpage>499</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1097/00008480-200112000-00002</pub-id>
<pub-id pub-id-type="pmid">11753097</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marks</surname><given-names>D. A.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Spencer</surname><given-names>D. D.</given-names></name><name><surname>Spencer</surname><given-names>S. S.</given-names></name></person-group> (<year>1992</year>). <article-title>Characteristics of intractable seizures following meningitis and encephalitis</article-title>. <source/>Neurology
<volume>42</volume>, <fpage>1513</fpage>–<lpage>1518</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.42.8.1513</pub-id>
<pub-id pub-id-type="pmid">1641145</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maxwell</surname><given-names>J. R.</given-names></name><name><surname>Denson</surname><given-names>J. L.</given-names></name><name><surname>Joste</surname><given-names>N. E.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Jantzie</surname><given-names>L. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Combined in utero hypoxia-ischemia and lipopolysaccharide administration in rats induces chorioamnionitis and a fetal inflammatory response syndrome</article-title>. <source/>Placenta
<volume>36</volume>, <fpage>1378</fpage>–<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1016/j.placenta.2015.10.009</pub-id>
<pub-id pub-id-type="pmid">26601766</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meli</surname><given-names>D. N.</given-names></name><name><surname>Loeffler</surname><given-names>J. M.</given-names></name><name><surname>Baumann</surname><given-names>P.</given-names></name><name><surname>Neumann</surname><given-names>U.</given-names></name><name><surname>Buhl</surname><given-names>T.</given-names></name><name><surname>Leppert</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex</article-title>. <source/>J. Neuroimmunol.
<volume>151</volume>, <fpage>6</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2004.01.026</pub-id>
<pub-id pub-id-type="pmid">15145598</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>U.</given-names></name></person-group> (<year>2014</year>). <article-title>Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems</article-title>. <source/>Biol. Psychiatry
<volume>75</volume>, <fpage>307</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.07.011</pub-id>
<pub-id pub-id-type="pmid">23938317</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moriyama</surname><given-names>C.</given-names></name><name><surname>Galic</surname><given-names>M. A.</given-names></name><name><surname>Mychasiuk</surname><given-names>R.</given-names></name><name><surname>Pittman</surname><given-names>Q. J.</given-names></name><name><surname>Perrot</surname><given-names>T. S.</given-names></name><name><surname>Currie</surname><given-names>R. W.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Prenatal transport stress, postnatal maternal behavior, and offspring sex differentially affect seizure susceptibility in young rats</article-title>. <source/>Epilepsy Beh.
<volume>29</volume>, <fpage>19</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2013.06.017</pub-id>
</mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nardou</surname><given-names>R.</given-names></name><name><surname>Ferrari</surname><given-names>D. C.</given-names></name><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Mechanisms and effects of seizures in the immature brain</article-title>. <source/>Semin. Fetal Neonatal Med.
<volume>18</volume>, <fpage>175</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/j.siny.2013.02.003</pub-id>
<pub-id pub-id-type="pmid">23702158</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nasr</surname><given-names>I. W.</given-names></name><name><surname>Chun</surname><given-names>Y.</given-names></name><name><surname>Kannan</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Neuroimmune responses in the developing brain following traumatic brain injury</article-title>. <source/>Exp. Neurol.
<volume>320</volume>, <fpage>112957</fpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2019.112957</pub-id>
<pub-id pub-id-type="pmid">31108085</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Norgaard</surname><given-names>M.</given-names></name><name><surname>Ehrenstein</surname><given-names>V.</given-names></name><name><surname>Nielsen</surname><given-names>R. B.</given-names></name><name><surname>Bakketeig</surname><given-names>L. S.</given-names></name><name><surname>Sorensen</surname><given-names>H. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Maternal use of antibiotics, hospitalisation for infection during pregnancy, and risk of childhood epilepsy: a population-based cohort study</article-title>. <source/>PloS One
<volume>7</volume>, <fpage>e30850</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0030850</pub-id>
<pub-id pub-id-type="pmid">22295115</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Numis</surname><given-names>A. L.</given-names></name><name><surname>Foster-Barber</surname><given-names>A.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Rogers</surname><given-names>E. E.</given-names></name><name><surname>Barkovich</surname><given-names>A. J.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Early changes in pro-inflammatory cytokine levels in neonates with encephalopathy are associated with remote epilepsy</article-title>. <source/>Pediatr. Res. <volume>86</volume>, <fpage>616</fpage>–<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1038/s41390-019-0473-x</pub-id>
<pub-id pub-id-type="pmid">31234194</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Omran</surname><given-names>A.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Xiang</surname><given-names>Q. L.</given-names></name><name><surname>Xue</surname><given-names>J.</given-names></name><name><surname>Gan</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Interleukin-1beta and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy</article-title>. <source/>Epilepsia
<volume>53</volume>, <fpage>1215</fpage>–<lpage>1224</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03540.x</pub-id>
<pub-id pub-id-type="pmid">22708826</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ostergard</surname><given-names>T.</given-names></name><name><surname>Sweet</surname><given-names>J.</given-names></name><name><surname>Kusyk</surname><given-names>D.</given-names></name><name><surname>Herring</surname><given-names>E.</given-names></name><name><surname>Miller</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Animal models of post-traumatic epilepsy</article-title>. <source/>J. Neurosci. Methods
<volume>15</volume>, <fpage>50</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2016.03.023</pub-id>
</mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patel</surname><given-names>D. C.</given-names></name><name><surname>Tewari</surname><given-names>B. P.</given-names></name><name><surname>Chaunsali</surname><given-names>L.</given-names></name><name><surname>Sontheimer</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Neuron-glia interactions in the pathophysiology of epilepsy</article-title>. <source/>Nat. Rev. Neurosci.
<volume>20</volume>, <fpage>282</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1038/s41583-019-0126-4</pub-id>
<pub-id pub-id-type="pmid">30792501</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patterson</surname><given-names>K. P.</given-names></name><name><surname>Brennan</surname><given-names>G. P.</given-names></name><name><surname>Curran</surname><given-names>M.</given-names></name><name><surname>Kinney-Lang</surname><given-names>E.</given-names></name><name><surname>Dube</surname><given-names>C.</given-names></name><name><surname>Rashid</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Rapid, coordinate inflammatory responses after experimental febrile status epilepticus: implications for epileptogenesis</article-title>. <source/>eNeuro. <volume>2</volume> (<issue>5</issue>), <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1523/ENEURO.0034-15.2015</pub-id>
</mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Arora</surname><given-names>N.</given-names></name><name><surname>Lau</surname><given-names>M.</given-names></name><name><surname>Lim</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Effects of neonatal hypoxic-ischemic episodes on late seizure outcomes in C57 black mice</article-title>. <source/>Epilepsy Res.
<volume>111</volume>, <fpage>142</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2015.01.009</pub-id>
<pub-id pub-id-type="pmid">25769378</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Holmes</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Microglial priming in neurodegenerative disease</article-title>. <source/>Nat. Rev. Neurol.
<volume>10</volume>, <fpage>217</fpage>–<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2014.38</pub-id>
<pub-id pub-id-type="pmid">24638131</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pineda</surname><given-names>E.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>You</surname><given-names>S. J.</given-names></name><name><surname>Auvin</surname><given-names>S.</given-names></name><name><surname>Sankar</surname><given-names>R.</given-names></name><name><surname>Mazarati</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Maternal immune activation promotes hippocampal kindling epileptogenesis in mice</article-title>. <source/>Ann. Neurol.
<volume>74</volume>, <fpage>11</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1002/ana.23898</pub-id>
<pub-id pub-id-type="pmid">23907982</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pullela</surname><given-names>R.</given-names></name><name><surname>Raber</surname><given-names>J.</given-names></name><name><surname>Pfankuch</surname><given-names>T.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name><name><surname>Claus</surname><given-names>C. P.</given-names></name><name><surname>Koh</surname><given-names>S.-E.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Traumatic injury to the immature brain results in progressive neuronal loss, hyperactivity and delayed cognitive impairments</article-title>. <source/>Dev. Neurosci.
<volume>28</volume>, <fpage>396</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1159/000094166</pub-id>
<pub-id pub-id-type="pmid">16943663</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raschilas</surname><given-names>F.</given-names></name><name><surname>Wolff</surname><given-names>M.</given-names></name><name><surname>Delatour</surname><given-names>F.</given-names></name><name><surname>Chaffaut</surname><given-names>C.</given-names></name><name><surname>T.</surname><given-names>D. B.</given-names></name><name><surname>Chevret</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study</article-title>. <source/>Clin. Infect. Dis.
<volume>35</volume>, <fpage>254</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1086/341405</pub-id>
<pub-id pub-id-type="pmid">12115090</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ravizza</surname><given-names>T.</given-names></name><name><surname>Rizzi</surname><given-names>M.</given-names></name><name><surname>Perego</surname><given-names>C.</given-names></name><name><surname>Richichi</surname><given-names>C.</given-names></name><name><surname>Veliskova</surname><given-names>J.</given-names></name><name><surname>Moshe</surname><given-names>S. L.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Inflammatory response and glia activation in developing rat hippocampus after status epilepticus</article-title>. <source/>Epilepsia
<volume>46 Suppl 5</volume>, <fpage>113</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2005.01006.x</pub-id>
<pub-id pub-id-type="pmid">15987264</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ravizza</surname><given-names>T.</given-names></name><name><surname>Noe</surname><given-names>F.</given-names></name><name><surname>Zardoni</surname><given-names>D.</given-names></name><name><surname>Vaghi</surname><given-names>V.</given-names></name><name><surname>Sifringer</surname><given-names>M.</given-names></name><name><surname>Vezzani</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production</article-title>. <source/>Neurobiol. Dis.
<volume>31</volume>, <fpage>327</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.05.007</pub-id>
<pub-id pub-id-type="pmid">18632279</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ravizza</surname><given-names>T.</given-names></name><name><surname>Balosso</surname><given-names>S.</given-names></name><name><surname>Vezzani</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Inflammation and prevention of epileptogenesis</article-title>. <source/>Neurosci. Lett.
<volume>497</volume>, <fpage>223</fpage>–<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2011.02.040</pub-id>
<pub-id pub-id-type="pmid">21362451</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reid</surname><given-names>A. Y.</given-names></name><name><surname>Riazi</surname><given-names>K.</given-names></name><name><surname>Teskey</surname><given-names>G. C.</given-names></name><name><surname>Pittman</surname><given-names>Q. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Increased excitability and molecular changes in adult rats after a febrile seizure</article-title>. <source/>Epilepsia
<volume>54</volume>, <fpage>e45</fpage>–<lpage>e48</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12061</pub-id>
<pub-id pub-id-type="pmid">23293960</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Riazi</surname><given-names>K.</given-names></name><name><surname>Galic</surname><given-names>M. A.</given-names></name><name><surname>Pittman</surname><given-names>Q. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability</article-title>. <source/>Epilepsy Res.
<volume>89</volume>, <fpage>34</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2009.09.004</pub-id>
<pub-id pub-id-type="pmid">19804959</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rice</surname><given-names>J. E. R.</given-names></name><name><surname>Vannucci</surname><given-names>R. C.</given-names></name><name><surname>Brierley</surname><given-names>J. B.</given-names></name></person-group> (<year>1981</year>). <article-title>The influence of immaturity on hypoxic-ischemic brain damage in the rat</article-title>. <source/>Ann. Neurol.
<volume>9</volume>, <fpage>131</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410090206</pub-id>
<pub-id pub-id-type="pmid">7235629</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rizzi</surname><given-names>M.</given-names></name><name><surname>Perego</surname><given-names>C.</given-names></name><name><surname>Aliprandi</surname><given-names>M.</given-names></name><name><surname>Richichi</surname><given-names>C.</given-names></name><name><surname>Ravizza</surname><given-names>T.</given-names></name><name><surname>Colella</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development</article-title>. <source/>Neurobiol. Dis.
<volume>14</volume>, <fpage>494</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2003.08.001</pub-id>
<pub-id pub-id-type="pmid">14678765</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodriguez-Alvarez</surname><given-names>N.</given-names></name><name><surname>Jimenez-Mateos</surname><given-names>E. M.</given-names></name><name><surname>Dunleavy</surname><given-names>M.</given-names></name><name><surname>Waddington</surname><given-names>J. L.</given-names></name><name><surname>Boylan</surname><given-names>G. B.</given-names></name><name><surname>Henshall</surname><given-names>D. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Effects of hypoxia-induced neonatal seizures on acute hippocampal injury and later-life seizure susceptibility and anxiety-related behavior in mice</article-title>. <source/>Neurobiol. Dis.
<volume>83</volume>, <fpage>100</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2015.08.023</pub-id>
<pub-id pub-id-type="pmid">26341542</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saghazadeh</surname><given-names>A.</given-names></name><name><surname>Gharedaghi</surname><given-names>M.</given-names></name><name><surname>Meysamie</surname><given-names>A.</given-names></name><name><surname>Bauer</surname><given-names>S.</given-names></name><name><surname>Rezaei</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Proinflammatory and anti-inflammatory cytokines in febrile seizures and epilepsy: systematic review and meta-analysis</article-title>. <source/>Rev. Neurosci.
<volume>25</volume>, <fpage>281</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1515/revneuro-2013-0045</pub-id>
<pub-id pub-id-type="pmid">24515998</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saltik</surname><given-names>S.</given-names></name><name><surname>Angay</surname><given-names>A.</given-names></name><name><surname>Ozkara</surname><given-names>C. E. A.</given-names></name></person-group> (<year>2003</year>). <article-title>A retrospective analysis of patients with febrile seizures followed by epilepsy</article-title>. <source/>Seizure
<volume>12</volume>, <fpage>211</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1016/S1059-1311(02)00226-1</pub-id>
<pub-id pub-id-type="pmid">12763467</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salzberg</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>G.</given-names></name><name><surname>Supit</surname><given-names>L.</given-names></name><name><surname>Jones</surname><given-names>N. C.</given-names></name><name><surname>Morris</surname><given-names>M. J.</given-names></name><name><surname>Rees</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Early postnatal stress confers enduring vulnerability to limbic epileptogenesis</article-title>. <source/>Epilepsia
<volume>48</volume>, <fpage>2079</fpage>–<lpage>2085</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01246.x</pub-id>
<pub-id pub-id-type="pmid">17999745</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Semple</surname><given-names>B. D.</given-names></name><name><surname>Blomgren</surname><given-names>K.</given-names></name><name><surname>Gimlin</surname><given-names>K.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name><name><surname>Noble-Haeusslein</surname><given-names>L. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species</article-title>. <source/>Prog. Neurobiol.
<volume>106-107</volume>, <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2013.04.001</pub-id>
<pub-id pub-id-type="pmid">23583307</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Semple</surname><given-names>B. D.</given-names></name><name><surname>O'brien</surname><given-names>T. J.</given-names></name><name><surname>Gimlin</surname><given-names>K.</given-names></name><name><surname>Wright</surname><given-names>D. K.</given-names></name><name><surname>Kim</surname><given-names>S. E.</given-names></name><name><surname>Casillas-Espinosa</surname><given-names>P. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Interleukin-1 receptor in seizure susceptibility after traumatic injury to the pediatric brain</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>7864</fpage>–<lpage>7877</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0982-17.2017</pub-id>
<pub-id pub-id-type="pmid">28724747</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Setkowicz</surname><given-names>Z.</given-names></name><name><surname>Kosonowska</surname><given-names>E.</given-names></name><name><surname>Janeczko</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Inflammation in the developing rat modulates astroglial reactivity to seizures in the mature brain</article-title>. <source/>J. Anat.
<volume>231</volume>, <fpage>366</fpage>–<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1111/joa.12636</pub-id>
<pub-id pub-id-type="pmid">28597918</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Mou</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Postnatal activation of TLR4 in astrocytes promotes excitatory synaptogenesis in hippocampal neurons</article-title>. <source/>J. Cell Biol.
<volume>215</volume>, <fpage>719</fpage>–<lpage>734</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201605046</pub-id>
<pub-id pub-id-type="pmid">27920126</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simao</surname><given-names>F.</given-names></name><name><surname>Oliveria</surname><given-names>V. H.</given-names></name><name><surname>Nunes</surname><given-names>M. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Enhanced susceptibility to seizures modulated by high interleukin-1beta levels during early life malnutrition</article-title>. <source/>Dev. Neurobiol.
<volume>76</volume>, <fpage>1150</fpage>–<lpage>1159</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22381</pub-id>
<pub-id pub-id-type="pmid">26818462</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Solek</surname><given-names>C. M.</given-names></name><name><surname>Farooqi</surname><given-names>N.</given-names></name><name><surname>Verly</surname><given-names>M.</given-names></name><name><surname>Lim</surname><given-names>T. K.</given-names></name><name><surname>Ruthazer</surname><given-names>E. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Maternal immune activation in neurodevelopmental disorders</article-title>. <source/>Dev. Dyn
<volume>247</volume>, <fpage>588</fpage>–<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.24612</pub-id>
<pub-id pub-id-type="pmid">29226543</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Somera-Molina</surname><given-names>K. C.</given-names></name><name><surname>Nair</surname><given-names>S.</given-names></name><name><surname>Van Eldik</surname><given-names>L. J.</given-names></name><name><surname>Watterson</surname><given-names>D. M.</given-names></name><name><surname>Wainwright</surname><given-names>M. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a ‘two-hit' seizure model</article-title>. <source/>Brain Res.
<volume>1282</volume>, <fpage>162</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.05.073</pub-id>
<pub-id pub-id-type="pmid">19501063</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sparkman</surname><given-names>N. L.</given-names></name><name><surname>Johnson</surname><given-names>R. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress</article-title>. <source/>Neuroimmunomodulation
<volume>15</volume>, <fpage>323</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1159/000156474</pub-id>
<pub-id pub-id-type="pmid">19047808</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stafstrom</surname><given-names>C. E.</given-names></name><name><surname>Thompson</surname><given-names>J. L.</given-names></name><name><surname>Holmes</surname><given-names>G. L.</given-names></name></person-group> (<year>1992</year>). <article-title>Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures</article-title>. <source/>Brain Res. Dev. Brain Res.
<volume>65</volume>, <fpage>227</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/0165-3806(92)90184-X</pub-id>
<pub-id pub-id-type="pmid">1572066</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Vestergaard</surname><given-names>M.</given-names></name><name><surname>Christensen</surname><given-names>J.</given-names></name><name><surname>Nahmais</surname><given-names>A. J.</given-names></name><name><surname>Olsen</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Prenatal exposure to maternal infections and epilepsy in childhood: a population-based cohort study</article-title>. <source/>Pediatics
<volume>121</volume>, <fpage>e1100</fpage>–<lpage>e1107</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2007-2316</pub-id>
</mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Vestergaard</surname><given-names>M.</given-names></name><name><surname>Christensen</surname><given-names>J.</given-names></name><name><surname>Olsen</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Prenatal exposure to elevated maternal body temperature and risk of epilepsy in childhood: a population-based pregnancy cohort study</article-title>. <source/>Paediatric Perinat. Epidemiol.
<volume>25</volume>, <fpage>53</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3016.2010.01143.x</pub-id>
</mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thomas</surname><given-names>R. H.</given-names></name><name><surname>Berkovic</surname><given-names>S. F.</given-names></name></person-group> (<year>2014</year>). <article-title>The hidden genetics of epilepsy-a clinically important new paradigm</article-title>. <source/>Nat. Rev. Neurol.
<volume>10</volume>, <fpage>283</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2014.62</pub-id>
<pub-id pub-id-type="pmid">24733163</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tong</surname><given-names>W.</given-names></name><name><surname>Igarashi</surname><given-names>T.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name><name><surname>Noble</surname><given-names>L. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Traumatic brain injury in the immature mouse brain: characterization of regional vulnerability</article-title>. <source/>Exp. Neurol.
<volume>176</volume>, <fpage>105</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1006/exnr.2002.7941</pub-id>
<pub-id pub-id-type="pmid">12093087</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>M. E.</given-names></name><name><surname>Stevens</surname><given-names>B.</given-names></name><name><surname>Sierra</surname><given-names>A.</given-names></name><name><surname>Wake</surname><given-names>H.</given-names></name><name><surname>Bessis</surname><given-names>A.</given-names></name><name><surname>Nimmerjahn</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of microglia in the healthy brain</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>16064</fpage>–<lpage>16069</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4158-11.2011</pub-id>
<pub-id pub-id-type="pmid">22072657</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trinka</surname><given-names>E.</given-names></name><name><surname>Cock</surname><given-names>H.</given-names></name><name><surname>Hesdorffer</surname><given-names>D.</given-names></name><name><surname>Rossetti</surname><given-names>A. O.</given-names></name><name><surname>Scheffer</surname><given-names>I. E.</given-names></name><name><surname>Shinnar</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A definition and classification of status epilepticus–report of the ILAE task force on classification of status epilepticus</article-title>. <source/>Epilepsia
<volume>56</volume>, <fpage>1515</fpage>–<lpage>1523</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13121</pub-id>
<pub-id pub-id-type="pmid">26336950</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Gassen</surname><given-names>K. L.</given-names></name><name><surname>Hessel</surname><given-names>E. V.</given-names></name><name><surname>Ramakers</surname><given-names>G. M.</given-names></name><name><surname>Notenboom</surname><given-names>R. G.</given-names></name><name><surname>Wolterink-Donselaar</surname><given-names>I. G.</given-names></name><name><surname>Brakkee</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Characterization of febrile seizures and febrile seizure susceptibility in mouse inbred strains</article-title>. <source/>Genes Brain Behav.
<volume>7</volume>, <fpage>578</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2008.00393.x</pub-id>
<pub-id pub-id-type="pmid">18363854</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Viviani</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability</article-title>. <source/>Neuropharmacology
<volume>96</volume>, <fpage>70</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.10.027</pub-id>
<pub-id pub-id-type="pmid">25445483</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Conti</surname><given-names>M.</given-names></name><name><surname>De Luigi</surname><given-names>A.</given-names></name><name><surname>Ravizza</surname><given-names>T.</given-names></name><name><surname>Moneta</surname><given-names>D.</given-names></name><name><surname>Marchesi</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>5054</fpage>–<lpage>5065</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-12-05054.1999</pub-id>
<pub-id pub-id-type="pmid">10366638</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Balosso</surname><given-names>S.</given-names></name><name><surname>Ravizza</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>The role of cytokines in the pathophysiology of epilepsy</article-title>. <source/>Brain Behav. Immun.
<volume>22</volume>, <fpage>797</fpage>–<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2008.03.009</pub-id>
<pub-id pub-id-type="pmid">18495419</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>French</surname><given-names>J.</given-names></name><name><surname>Bartfai</surname><given-names>T.</given-names></name><name><surname>Baram</surname><given-names>T. Z.</given-names></name></person-group> (<year>2011</year>a). <article-title>The role of inflammation in epilepsy</article-title>. <source/>Nat. Rev. Neurol.
<volume>2011</volume>, <fpage>31</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2010.178</pub-id>
</mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Maroso</surname><given-names>M.</given-names></name><name><surname>Balosso</surname><given-names>S.</given-names></name><name><surname>Sanchez</surname><given-names>M. A.</given-names></name><name><surname>Bartfai</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>b). <article-title>IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperactivity and seizures</article-title>. <source/>Brain Behav. Immun.
<volume>25</volume>, <fpage>1281</fpage>–<lpage>1289</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2011.03.018</pub-id>
<pub-id pub-id-type="pmid">21473909</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Balosso</surname><given-names>S.</given-names></name><name><surname>Ravizza</surname><given-names>T.</given-names></name></person-group> (<year>2019</year>). <article-title>Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy</article-title>. <source/>Nat. Rev. Neurol.
<volume>15</volume>, <fpage>459</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1038/s41582-019-0217-x</pub-id>
<pub-id pub-id-type="pmid">31263255</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Volpe</surname><given-names>J. J.</given-names></name></person-group> (<year>1989</year>). <article-title>Neonatal seizures: current concepts and revised classification</article-title>. <source/>Pediatrics
<volume>84</volume>, <fpage>422</fpage>–<lpage>428</lpage>.<pub-id pub-id-type="pmid">2671912</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>P. F.</given-names></name><name><surname>Xiong</surname><given-names>X. Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y. C.</given-names></name><name><surname>Duan</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>Q. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment</article-title>. <source/>J. Neuroinflammation
<volume>12</volume>, <fpage>80</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0301-0</pub-id>
<pub-id pub-id-type="pmid">25928750</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Washington</surname><given-names>J.</given-names></name><name><surname>3rd Kumar</surname><given-names>U.</given-names></name><name><surname>Medel-Matus</surname><given-names>J. S.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Sankar</surname><given-names>R.</given-names></name><name><surname>Mazarati</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Cytokine-dependent bidirectional connection between impaired social behavior and susceptibility to seizures associated with maternal immune activation in mice</article-title>. <source/>Epilepsy Behav.
<volume>50</volume>, <fpage>40</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2015.05.040</pub-id>
<pub-id pub-id-type="pmid">26103532</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Webster</surname><given-names>K. M.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name><name><surname>Crack</surname><given-names>P.</given-names></name><name><surname>O'brien</surname><given-names>T. J.</given-names></name><name><surname>Shultz</surname><given-names>S. R.</given-names></name><name><surname>Semple</surname><given-names>B. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Inflammation in epileptogenesis after traumatic brain injury</article-title>. <source/>J. Neuroinflammation
<volume>14</volume>, <fpage>10</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-016-0786-1</pub-id>
<pub-id pub-id-type="pmid">28086980</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Webster</surname><given-names>K. M.</given-names></name><name><surname>Shultz</surname><given-names>S. R.</given-names></name><name><surname>Ozturk</surname><given-names>E.</given-names></name><name><surname>Dill</surname><given-names>L. K.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name><name><surname>Casillas-Espinosa</surname><given-names>P. M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: chronic neuroinflammatory, behavioral, and epileptogenic consequences</article-title>. <source/>Exp. Neurol.
<volume>320</volume>, <fpage>112979</fpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2019.112979</pub-id>
<pub-id pub-id-type="pmid">31229637</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weisman</surname><given-names>H.</given-names></name><name><surname>Fried</surname><given-names>I.</given-names></name><name><surname>Gilboa</surname><given-names>T.</given-names></name><name><surname>Bennett-Back</surname><given-names>O.</given-names></name><name><surname>Ekstein</surname><given-names>D.</given-names></name><name><surname>Shweiki</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Prevalence, characteristics, and long-term prognosis of epilepsy associated with pediatric brain tumors</article-title>. <source/>World Neurosurg.
<volume>109</volume>, <fpage>e594</fpage>–<lpage>e600</lpage>. <pub-id pub-id-type="doi">10.1016/j.wneu.2017.10.038</pub-id>
<pub-id pub-id-type="pmid">29054779</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>P. A.</given-names></name><name><surname>Dudek</surname><given-names>F. E.</given-names></name></person-group> (<year>2007</year>). <article-title>A chronic histopathological and electrophysiological analysis of a rodent hypoxic-ischemic brain injury model and its use as a model of epilepsy</article-title>. <source/>Neuroscience
<volume>149</volume>, <fpage>943</fpage>–<lpage>961</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.07.067</pub-id>
<pub-id pub-id-type="pmid">17935893</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>P. A.</given-names></name><name><surname>Dou</surname><given-names>P.</given-names></name><name><surname>Dudek</surname><given-names>F. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Epilepsy and synaptic reorganization in a perinatal rat model of hypoxia–ischemia</article-title>. <source/>Epilepsia
<volume>45</volume>, <fpage>1210</fpage>–<lpage>1218</lpage>. <pub-id pub-id-type="doi">10.1111/j.0013-9580.2004.60403.x</pub-id>
<pub-id pub-id-type="pmid">15461675</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wulsin</surname><given-names>A. C.</given-names></name><name><surname>Solomon</surname><given-names>M. B.</given-names></name><name><surname>Privitera</surname><given-names>M. D.</given-names></name><name><surname>Danzer</surname><given-names>S. C.</given-names></name><name><surname>Herman</surname><given-names>J. P.</given-names></name></person-group> (<year>2016</year>). <article-title>Hypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy</article-title>. <source/>Physiol. Behav.
<volume>166</volume>, <fpage>22</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2016.05.015</pub-id>
<pub-id pub-id-type="pmid">27195458</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wyatt-Johnson</surname><given-names>S. K.</given-names></name><name><surname>Herr</surname><given-names>S. A.</given-names></name><name><surname>Brewster</surname><given-names>A. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Status epilepticus triggers time-dependent alterations in microglia abundance and morphological phenotypes in the hippocampus</article-title>. <source/>Front. Neurol.
<volume>8</volume>, <elocation-id>700</elocation-id>. <pub-id pub-id-type="doi">10.3389/fneur.2017.00700</pub-id>
<pub-id pub-id-type="pmid">29326654</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Chau</surname><given-names>V.</given-names></name><name><surname>Sanguansermsri</surname><given-names>C.</given-names></name><name><surname>Muir</surname><given-names>K. E.</given-names></name><name><surname>Tam</surname><given-names>E. W. Y.</given-names></name><name><surname>Miller</surname><given-names>S. P.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Pattern of brain injury predicts long-term epilepsy following neonatal encephalopathy</article-title>. <source/>J. Child Neurol.
<volume>34</volume>, <fpage>199</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1177/0883073818822361</pub-id>
</mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yin</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>X. T.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J. W.</given-names></name><name><surname>Lei</surname><given-names>G. F.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Maternal immune activation increases seizure susceptibility in juvenile rat offspring</article-title>. <source/>Epilepsy Beh.
<volume>47</volume>, <fpage>93</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2015.04.018</pub-id>
</mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yuen</surname><given-names>A. W. C.</given-names></name><name><surname>Keezer</surname><given-names>M. R.</given-names></name><name><surname>Sander</surname><given-names>J. W.</given-names></name></person-group> (<year>2018</year>). <article-title>Epilepsy is a neurological and a systemic disorder</article-title>. <source/>Epilepsy Behav.
<volume>78</volume>, <fpage>57</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2017.10.010</pub-id>
<pub-id pub-id-type="pmid">29175221</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zaretsky</surname><given-names>M. V.</given-names></name><name><surname>Alexander</surname><given-names>J. M.</given-names></name><name><surname>Byrd</surname><given-names>W.</given-names></name><name><surname>Bawdon</surname><given-names>R. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Transfer of inflammatory cytokines across the placenta</article-title>. <source/>Obstet. Gynecol.
<volume>103</volume>, <fpage>546</fpage>–<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1097/01.AOG.0000114980.40445.83</pub-id>
<pub-id pub-id-type="pmid">14990420</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zupanc</surname><given-names>M. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Neonatal seizures</article-title>. <source/>Pediatr. Clin. North Am.
<volume>51</volume>, <fpage>961</fpage>–<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcl.2004.03.002</pub-id>
<pub-id pub-id-type="pmid">15275983</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>